Global Fertility Services Market, 2020-2027

2021
APRIL
FERTILITY SERVICES MARKET

AUTHOR(S):
Global Opportunity Analysis and Industry Forecast, 2020-2027
Kishor Sherkar,
Apoorva Srivastava &
Onkar Sumant
PAGES:
206
REPORT CODE:
A04206
INDUSTRY:
Life Sciences
911@alliedmarketresearch.com
+1-800-792-5285
U.S.: +1-503-894-6022
UK.: +44-845-528-1300
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
EMISPDF in-pwc001 from 13.234.188.75 on 2021-11-26 05:24:03 GMT. DownloadPDF.

Downloaded by in-pwc001 from 13.234.188.75 at 2021-11-26 05:24:03 GMT. EMIS. Unauthorized Distribution Prohibited.
ABOUT US
Allied Market Research is a full-service market research and business-consulting wing of Allied Analytics LLP
based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small
businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR
has a targeted view to provide business insights and consulting to assist its clients to make strategic business
decisions and achieve sustainable growth in their respective market domain.
TERMS OF USE
The electronic or hard copy of this report bears an underlying contractual agreement between Allied Market
Research and the buyer. The complete or part of the content of the report cannot be shared or made available
to other persons, other divisions, subsidiaries of same company or other companies. The reproduction or
redistribution of the report in any manner is strictly prohibited without the prior permission of Allied Market
Research. The publisher will, in-turn, regard the privacy of the purchaser and will keep it confidential. In case
the purchaser wishes to share the content of the report or the report proceeds with other members or
departments of company, the license type of the report should be upgraded depending upon the sharing
Global Fertility requirement. Additional copies for this report may also be order at discounted price for use by addition
Services Market readers/users. This publication is informative material and is not meant for managerial, legal or accounting
Opportunity Analysis advice. It should not be used for corporate guide, laboratory manual or endorsement of any product.
and Industry Forecast,
2020-2027
2
GO TO TOC Copyright © Allied Market Research | sales@alliedmarketresearch.com | www.alliedmarketresearch.com
LICENSE TERMS & CONDITIONS:
The license terms and conditions stated herein (the "License Terms" hereafter) grant non-exclusive rights
to AUTHORIZED USERS for using the product(s)/service(s) ("REPORT") offered by "Allied Market Research
("AMR") in any form, and is applicable to all orders (an "ORDER") processed by AMR. The agreement is related
to your use of the products and services offered by AMR. By placing the order, an individual ("you"), on his/her
own or on behalf of an organization, agrees to the License Terms. The License Terms shall be binding upon
the user on acceptance of the delivery of AMR’s research products (includes research reports, survey data,
company profiles, custom research services, and any other product created and owned by AMR) or consulting
assignments by AMR and any of its authorized distributors. The License Terms supersede and replace any
other agreement accepted by you with respect to a prior version of the product/service.
License Options:
AMR offers three types of non-exclusive, non-transferable machine-readable licenses, viz. Single User, Five
User, and Enterprise User options. Single User type entitles only ONE authorized user the right to store,
display, use, or stockpile the report. In the Five User license type, FIVE authorized users can access, store,
display, use, or stockpile the report. The Enterprise User license, the report can be circulated within an
organization and/or among its subsidiaries. Unauthorized access or distribution of AMR’s reports will be
considered as a serious breach of the terms and conditions as stated herewith and on AMR’s website. Any
violation of which shall be treated as per the applicable laws in the United States, India, or in the jurisdiction of
purchase. The products and services offered are the intellectual property of AMR, and are protected by
applicable copyright laws, international treaty provisions, and other applicable laws of the country in which
these are being used. The terms and conditions mentioned on AMR’s website stand applicable for users of this
Global Fertility document, so kindly visit the link below for more information.
Services Market
Opportunity Analysis https://www.alliedmarketresearch.com/terms-and-conditions
2020-2027
3
RELATED REPORTS
Global Infertility Treatment Market– Global Opportunity Analysis and Industry Forecast, 2020–2027
Infertility is inability of an individual to reproduce by natural way. Infertility is caused due to various reasons. The few reasons
include rise in maternal age, disorders related to occurrence of ovulation, tubal occlusion or blockage, sexually transmitted
infections, immune infertility, genetics, and infertility caused due to male factors. Treatment options in infertility are to
spread awareness, medications for assisting the development during the period of ovulation, In Vitro Fertilization (IVF),
Insemination among others.
Global IVF Services Market– Global Opportunity Analysis and Industry Forecast, 2019-2026
The global In vitro fertilization services market size generated $12,506 million in 2018, and is projected to reach $25,563
million by 2026, growing at a CAGR of 9.3% from 2019 to 2026. In vitro fertilization is an assisted reproductive technology
(ART), which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperm in vitro. The process involves
stimulating a woman's ovulatory, removing an ovum from the woman's ovaries, and letting sperm fertilize them in a liquid in
a laboratory.
Global Fertility
Services Market
Opportunity Analysis
2020-2027
4
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION....................................................................................... 26
1.1. Report description ......................................................................................................26
1.2. Key benefits for stakeholders ....................................................................................27
1.3. Key market segments .................................................................................................28
1.3.1. List of key players profiled in the report ..................................................................... 30
1.4. Research methodology ...............................................................................................31

1.4.1. Secondary research ............................................................................................................. 33
1.4.2. Primary research ................................................................................................................... 33
1.4.3. Analyst tools & models ...................................................................................................... 34
CHAPTER 2: EXECUTIVE SUMMARY............................................................................ 35

2.1. Key findings of the study ...........................................................................................37
Global Fertility 2.2. CXO perspective ..........................................................................................................37
Services Market CHAPTER 3: MARKET OVERVIEW ................................................................................ 39

Opportunity Analysis 3.1. Market definition and scope......................................................................................39
2020-2027 3.2. Key findings .................................................................................................................40
3.2.1. Top investment pockets..................................................................................................... 40
5
3.2.2. Top winning strategies ....................................................................................................... 41
3.3. Porter’s five force analysis .........................................................................................45

3.4. Government regulations ............................................................................................50
3.4.1. U.S. ............................................................................................................................................. 50
3.4.2. Europe ...................................................................................................................................... 51
3.5. Market dynamics .........................................................................................................53

3.5.1. Drivers ....................................................................................................................................... 54
3.5.1.1. Continuous decline in fertility rates ......................................................................... 54

3.5.1.2. Delayed pregnancies in women ................................................................................ 54
3.5.1.3. Technological advancements with respect to fertility treatment ................. 55
3.5.2. Restraints ................................................................................................................................. 56
3.5.2.1. High treatment costs of ARTs in developed countries ..................................... 56

3.5.2.2. Inadequate reimbursement policies ........................................................................ 56
3.5.3. Opportunity ............................................................................................................................ 57

Global Fertility
Services Market 3.5.3.1. Rise in fertility tourism .................................................................................................. 57
3.6. COVID-19 impact on the fertility services market ..................................................58

and Industry Forecast, 3.7. Number of fertility service centers ...........................................................................59
2020-2027
CHAPTER 4: FERTILITY SERVICES MARKET, BY PROCEDURE ................................... 61
6
4.1. Overview ......................................................................................................................61
4.1.1. Market size and forecast.................................................................................................... 62
4.2. IVF with ICSI .................................................................................................................63

4.2.1. Key market trends, growth factors, and opportunities .......................................... 63
4.3. IUI ..................................................................................................................................65

4.4. IVF without ICSI ...........................................................................................................67

4.4.1. Key market trends growth factors, and opportunities ........................................... 67
4.5. Surrogacy .....................................................................................................................68

Global Fertility 4.5.2. Market size and forecast.................................................................................................... 69
Services Market
4.6. Others ...........................................................................................................................70
2020-2027 4.6.2. Market size and forecast.................................................................................................... 71
7
CHAPTER 5: FERTILITY SERVICES MARKET, BY SERVICE .......................................... 72
5.1. Overview ......................................................................................................................72
5.2. Fresh non-donor ..........................................................................................................74

5.3. Frozen non-donor .......................................................................................................75

5.4. Egg & embryo banking ..............................................................................................77

5.5. Fresh donor ..................................................................................................................79

5.6. Frozen donor ...............................................................................................................81

Global Fertility CHAPTER 6: FERTILITY SERVICES MARKET, BY END USER....................................... 82
Services Market
6.1. Overview ......................................................................................................................82
and Industry Forecast, 6.1.1. Market size and forecast.................................................................................................... 83
2020-2027
6.2. Fertility clinics ..............................................................................................................84
8
6.3. Hospitals.......................................................................................................................85
6.4. Surgical centers ...........................................................................................................87

6.5. Clinical research institutes .........................................................................................88

CHAPTER 7: FERTILITY SERVICES MARKET, BY REGION .......................................... 89

7.1. Overview ......................................................................................................................89
7.2. North America .............................................................................................................91

7.2.2. Market size and forecast, by country ............................................................................ 92

Global Fertility 7.2.3. Market size and forecast, by procedure ...................................................................... 93
Services Market
7.2.4. Market size and forecast, by service ............................................................................. 94
and Industry Forecast, 7.2.5. Market size and forecast, by end user .......................................................................... 95
2020-2027
7.2.5.1. U.S. market size and forecast, by procedure ........................................................ 96
9
7.2.5.2. U.S. Market size and forecast, by service ............................................................... 97
7.2.5.3. U.S. Market size and forecast, by end user ........................................................... 98
7.2.5.4. Canada size and forecast, by procedure ................................................................ 99
7.2.5.5. Canada Market size and forecast, by service...................................................... 100
7.2.5.6. Canada Market size and forecast, by end user .................................................. 101
7.2.5.7. Mexico market size and forecast, by procedure ............................................... 102
7.2.5.8. Mexico Market size and forecast, by service ...................................................... 103
7.2.5.9. Mexico Market size and forecast, by end user .................................................. 104
7.3. Europe ....................................................................................................................... 105

7.3.1. Key market trends, growth factors, and opportunities ........................................ 105
7.3.2. Europe Market size and forecast, by country .......................................................... 106
7.3.3. Europe Market size and forecast, by procedure ..................................................... 107
7.3.4. Europe market size and forecast, by service ............................................................ 108
7.3.5. Europe market size and forecast, by end user ........................................................ 109
Global Fertility
7.3.5.1. Germany market size and forecast, by procedure............................................ 110
Services Market
7.3.5.2. Germany market size and forecast, by service................................................... 111
and Industry Forecast, 7.3.5.3. Germany market size and forecast, by end user ............................................... 112
2020-2027 7.3.5.4. France market size and forecast, by procedure................................................. 113
7.3.5.5. France market size and forecast, by service........................................................ 114
10
7.3.5.6. France market size and forecast, by end user .................................................... 115
7.3.5.7. UK market size and forecast, by procedure ........................................................ 116
7.3.5.8. UK market size and forecast, by service ............................................................... 117
7.3.5.9. UK market size and forecast, by end user ........................................................... 118
7.3.5.10. Italy market size and forecast, by procedure ..................................................... 119
7.3.5.11. Italy Market size and forecast, by service ............................................................ 120
7.3.5.12. Italy market size and forecast, by end user ......................................................... 121
7.3.5.13. Spain market size and forecast, by procedure ................................................... 122
7.3.5.14. Spain Market size and forecast, by service.......................................................... 123
7.3.5.15. Spain Market size and forecast, by end user ...................................................... 124
7.3.5.16. Russia market size and forecast, by procedure ................................................. 125
7.3.5.17. Russia Market size and forecast, by service ........................................................ 126
7.3.5.18. Russia market size and forecast, by end user .................................................... 127
7.3.5.19. Rest of Europe market size and forecast, by procedure ................................ 128
7.3.5.20. Rest of Europe market size and forecast, by service ....................................... 129
Global Fertility
Services Market 7.3.5.21. Rest of Europe market size and forecast, by end user ................................... 130
7.4. Asia-Pacific................................................................................................................ 131

and Industry Forecast, 7.4.1. Key market trends, growth factors, and opportunities ........................................ 131
2020-2027
7.4.2. Market size and forecast, by country .......................................................................... 132
11
7.4.3. Asia-Pacific market size and forecast, by procedure ............................................ 133
7.4.4. Asia-Pacific market size and forecast, by service ................................................... 134
7.4.5. Asia-Pacific market size and forecast, by end user ................................................ 135
7.4.5.1. Japan market size and forecast, by procedure .................................................. 136

7.4.5.2. Japan market size and forecast, by service ......................................................... 137
7.4.5.3. Japan market size and forecast, by end user...................................................... 138
7.4.5.4. India market size and forecast, by procedure .................................................... 139
7.4.5.5. India Market size and forecast, by service ........................................................... 140
7.4.5.6. India market size and forecast, by end user ....................................................... 141
7.4.5.7. China market size and forecast, by procedure .................................................. 142
7.4.5.8. China Market size and forecast, by service ......................................................... 143
7.4.5.9. China Market size and forecast, by end user ..................................................... 144
7.4.5.10. Australia market size and forecast, by procedure ............................................ 145
7.4.5.11. Australia Market size and forecast, by service ................................................... 146
Global Fertility 7.4.5.12. Australia Market size and forecast, by end user ............................................... 147
Services Market 7.4.5.13. South Korea market size and forecast, by procedure ..................................... 148
Opportunity Analysis 7.4.5.14. South Korea market size and forecast, by service ............................................ 149
2020-2027 7.4.5.15. South Korea market size and forecast, by end user ........................................ 150
7.4.5.16. Rest of Asia-Pacific market size and forecast, by procedure ....................... 151
12
7.4.5.17. Rest of Asia-Pacific Market size and forecast, by service .............................. 152
7.4.5.18. Rest of Asia-Pacific market size and forecast, by end user ........................... 153
7.5. LAMEA ....................................................................................................................... 154

7.5.1. Key market trends, growth factors, and opportunities ........................................ 154
7.5.2. Market size and forecast, by country .......................................................................... 155
7.5.3. LAMEA market size and forecast, by procedure ..................................................... 156
7.5.4. LAMEA market size and forecast, by service ............................................................ 157
7.5.5. LAMEA market size and forecast, by end user ........................................................ 158
7.5.5.1. Latin America market size and forecast, by procedure .................................. 159
7.5.5.2. Latin America market size and forecast, by service ......................................... 160
7.5.5.3. Latin America market size and forecast, by end user...................................... 161
7.5.5.4. Middle East market size and forecast.................................................................... 162
7.5.5.5. Middle East market size and forecast, by service ............................................. 163
7.5.5.6. Middle East market size and forecast, by end user.......................................... 164
Global Fertility
7.5.5.7. Africa market size and forecast................................................................................ 165
Services Market
7.5.5.8. Africa market size and forecast, by service ......................................................... 166
and Industry Forecast, 7.5.5.9. Africa market size and forecast, by end user...................................................... 167
2020-2027
CHAPTER 8: COMPANY PROFILES............................................................................. 168
13
8.1. APOLLO HOSPITALS ENTERPRISE LTD. ................................................................. 168
8.1.1. Company overview ............................................................................................................ 168
8.1.2. Company snapshot ............................................................................................................ 169
8.1.3. Operating business segments ....................................................................................... 169
8.1.4. Product portfolio ................................................................................................................ 170
8.1.5. Business performance....................................................................................................... 171
8.1.6. Key strategic moves and developments .................................................................... 172
8.2. CARE FERTILITY GROUP LTD................................................................................... 173


Global Fertility 8.3. CAROLINAS FERTILITY INSTITUTE ......................................................................... 176
Services Market
and Industry Forecast, 8.3.2. Company snapshot ............................................................................................................ 176
2020-2027
14
8.4. CITY FERTILITY .......................................................................................................... 178

8.5. FERTILITY ASSOCIATES LIMITED ............................................................................ 181

8.6. GENEA LIMITED ........................................................................................................ 183

Global Fertility 8.6.1. Company overview ............................................................................................................ 183
Services Market
and Industry Forecast, 8.6.3. Operating business segments ....................................................................................... 184
2020-2027
15
8.7. MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK) ............... 187
8.7.4. roduct portfolio ................................................................................................................... 189
8.8. MONASH IVF GROUP LIMITED ............................................................................... 192


Global Fertility 8.8.6. Key strategic moves and developments .................................................................... 195
Services Market
8.9. PROGYNY INC. .......................................................................................................... 196
and Industry Forecast, 8.9.1. Company overview ............................................................................................................ 196
2020-2027
16
8.10. VIRTUS HEALTH ....................................................................................................... 200

Global Fertility
Services Market
2020-2027
17
LIST OF TABLES
TABLE 01. KEY ART AND FERTILITY SERVICES LEGISLATION IN EUROPE: OVERVIEW ............................................................52
TABLE 02. GLOBAL FERTILITY SERVICES MARKET, BY PROCEDURE, 2019–2027 ($MILLION) .............................................62
TABLE 03. FERTILITY SERVICES MARKET FOR IVF WITH ICSI, BY REGION, 2019–2027 ($MILLION) ...................................64
TABLE 04. FERTILITY SERVICES MARKET FOR IUI, BY REGION, 2019–2027 ($MILLION).......................................................66
TABLE 05. FERTILITY SERVICES MARKET FOR IVF WITHOUT ICSI, BY REGION, 2019–2027 ($MILLION) ............................68
TABLE 06. FERTILITY SERVICES MARKET FOR SURROGACY, BY REGION, 2019–2027 ($MILLION).....................................70
TABLE 07. FERTILITY SERVICES MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION).............................................71
TABLE 08. GLOBAL FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) .....................................................73
TABLE 09. FERTILITY SERVICES MARKET FOR FRESH NON-DONOR, BY REGION, 2019-2027 ($MILLION) .........................75
TABLE 10. FERTILITY SERVICES MARKET FOR FROZEN NON-DONOR, BY REGION, 2019-2027 ($MILLION) ......................76
TABLE 11. FERTILITY SERVICES MARKET FOR EGG AND EMBRYO BANKING, BY REGION, 2019-2027
($MILLION).........................................................................................................................................................................78
TABLE 12. FERTILITY SERVICES MARKET FOR FRESH DONOR, BY REGION, 2019-2027 ($MILLION) ..................................80
TABLE 13. FERTILITY SERVICES MARKET FOR FROZEN DONOR, BY REGION, 2019-2027 ($MILLION)................................81
Global Fertility TABLE 14. GLOBAL FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ..................................................83
Services Market TABLE 15. FERTILITY SERVICES MARKET FOR IVF FERTILITY CLINICS, BY REGION, 2019-2027 ($MILLION) .....................85
Opportunity Analysis TABLE 16. FERTILITY SERVICES MARKET FOR HOSPITALS, BY REGION, 2019-2027 ($MILLION) ........................................86
2020-2027 TABLE 17. FERTILITY SERVICES MARKET FOR IVF SURGICAL CENTERS, BY REGION, 2019-2027 ($MILLION) ..................87
18
TABLE 18. FERTILITY SERVICES MARKET FOR CLINICAL RESEARCH INSTITUTES, BY REGION, 2019-2027
($MILLION).........................................................................................................................................................................88
TABLE 19. GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2019-2027 ($MILLION) .......................................................90
TABLE 20. NORTH AMERICA FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION) ...................................92
TABLE 21. NORTH AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ..............................93
TABLE 22. NORTH AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) .....................................94
TABLE 23. NORTH AMERICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ..................................95
TABLE 24. U.S. FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ......................................................96
TABLE 25. U.S. FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) .............................................................97
TABLE 26. U.S. FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ..........................................................98
TABLE 27. CANADA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) .............................................99
TABLE 28. CANADA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) .................................................. 100
TABLE 29. CANADA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) .............................................. 101
TABLE 30. MEXICO FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)............................................ 102
TABLE 31. MEXICO FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ................................................... 103
TABLE 32. MEXICO FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ................................................ 104
Global Fertility TABLE 33. EUROPE FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION) ................................................ 106
Services Market
TABLE 34. EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ........................................... 107
Opportunity Analysis TABLE 35. EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) .................................................. 108
2020-2027 TABLE 36. EUROPE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ............................................... 109
TABLE 37. GERMANY FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ....................................... 110
19
TABLE 38. GERMANY FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)............................................... 111
TABLE 39. GERMANY FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ........................................... 112
TABLE 40. FRANCE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ........................................... 113
TABLE 41. FRANCE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) .................................................. 114
TABLE 42. FRANCE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ............................................... 115
TABLE 43. UK FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ..................................................... 116
TABLE 44. UK FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ............................................................ 117
TABLE 45. UK FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ......................................................... 118
TABLE 46. ITALY FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ................................................ 119
TABLE 47. ITALY FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ....................................................... 120
TABLE 48. ITALY FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) .................................................... 121
TABLE 49. SPAIN FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) .............................................. 122
TABLE 50. SPAIN FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ...................................................... 123
TABLE 51. SPAIN FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)................................................... 124
TABLE 52. RUSSIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ............................................ 125
Global Fertility TABLE 53. RUSSIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ................................................... 126
Services Market TABLE 54. RUSSIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ................................................ 127
TABLE 55. REST OF EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ........................... 128
and Industry Forecast, TABLE 56. REST OF EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) .................................. 129
2020-2027 TABLE 57. REST OF EUROPE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ............................... 130
TABLE 58. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION) ....................................... 132
20
TABLE 59. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) .................................. 133
TABLE 60. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ......................................... 134
TABLE 61. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ...................................... 135
TABLE 62. JAPAN FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) .............................................. 136
TABLE 63. JAPAN FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ..................................................... 137
TABLE 64. JAPAN FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) .................................................. 138
TABLE 65. INDIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)................................................ 139
TABLE 66. INDIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ....................................................... 140
TABLE 67. INDIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) .................................................... 141
TABLE 68. CHINA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) .............................................. 142
TABLE 69. CHINA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)...................................................... 143
TABLE 70. CHINA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) .................................................. 144
TABLE 71. AUSTRALIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ..................................... 145
TABLE 72. AUSTRALIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ............................................. 146
TABLE 73. AUSTRALIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION).......................................... 147
Global Fertility TABLE 74. SOUTH KOREA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ................................ 148
Services Market TABLE 75. SOUTH KOREA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ....................................... 149
TABLE 76. SOUTH KOREA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) .................................... 150
and Industry Forecast, TABLE 77. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) .................................. 151
2020-2027 TABLE 78. REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ......................... 152
TABLE 79. REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ...................... 153
21
TABLE 80. LAMEA FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION) .................................................. 155
TABLE 81. LAMEA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ............................................. 156
TABLE 82. LAMEA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) .................................................... 157
TABLE 83. LAMEA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ................................................. 158
TABLE 84. LATIN AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ............................. 159
TABLE 85. LATIN AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) ..................................... 160
TABLE 86. LATIN AMERICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION).................................. 161
TABLE 87. MIDDLE EAST FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ................................. 162
TABLE 88. MIDDLE EAST FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)......................................... 163
TABLE 89. MIDDLE EAST FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ..................................... 164
TABLE 90. AFRICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION) ............................................ 165
TABLE 91. AFRICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION) .................................................... 166
TABLE 92. AFRICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION) ................................................ 167
TABLE 93. APOLLO HOSPITALS: COMPANY SNAPSHOT ............................................................................................................ 169
TABLE 94. APOLLO HOSPITALS: OPERATING SEGMENTS.......................................................................................................... 169
Global Fertility TABLE 95. APOLLO HOSPITALS: PRODUCT PORTFOLIO............................................................................................................. 170
Services Market TABLE 96. CARE FERTILITY: COMPANY SNAPSHOT .................................................................................................................... 173
TABLE 97. CARE FERTILITY: PRODUCT PORTFOLIO .................................................................................................................... 174

and Industry Forecast, TABLE 98. CAROLINAS FERTILITY INSTITUTE: COMPANY SNAPSHOT ..................................................................................... 176
2020-2027 TABLE 99. CAROLINAS FERTILITY INSTITUTE: PRODUCT PORTFOLIO...................................................................................... 177
TABLE 100. CITY FERTILITY: COMPANY SNAPSHOT ...................................................................................................................... 178
22
TABLE 101. CITY FERTILITY: PRODUCT PORTFOLIO ...................................................................................................................... 179
TABLE 102. FERTILITY ASSOCIATES: COMPANY SNAPSHOT ....................................................................................................... 181
TABLE 103. FERTILITY ASSOCIATES: OPERATING SEGMENTS .................................................................................................... 182
TABLE 104. FERTILITY ASSOCIATES: PRODUCT PORTFOLIO ....................................................................................................... 182
TABLE 105. GENEA LIMITED: COMPANY SNAPSHOT .................................................................................................................... 184
TABLE 106. GENEA LIMITED: OPERATING SEGMENTS ................................................................................................................. 184
TABLE 107. GENEA LIMITED: PRODUCT PORTFOLIO .................................................................................................................... 185
TABLE 108. MEDICOVER: COMPANY SNAPSHOT........................................................................................................................... 188
TABLE 109. MEDICOVER: OPERATING SEGMENTS ........................................................................................................................ 188
TABLE 110. MEDICOVER: PRODUCT PORTFOLIO ........................................................................................................................... 189
TABLE 111. MVF: COMPANY SNAPSHOT......................................................................................................................................... 192
TABLE 112. MVF: PRODUCT PORTFOLIO ......................................................................................................................................... 193
TABLE 113. PROGYNY: COMPANY SNAPSHOT .............................................................................................................................. 196
TABLE 114. PROGYNY: PRODUCT PORTFOLIO ............................................................................................................................... 197
TABLE 115. VIRTUS HEALTH: COMPANY SNAPSHOT .................................................................................................................... 200
Global Fertility TABLE 116. VIRTUS HEALTH: OPERATING SEGMENTS ................................................................................................................. 201
Services Market TABLE 117. VIRTUS HEALTH: PRODUCT PORTFOLIO .................................................................................................................... 202
2020-2027
23
LIST OF FIGURES
FIGURE 01. FERTILITY SERVICES MARKET: MARKET SEGMENTATION .........................................................................................39
FIGURE 02. TOP INVESTMENT POCKETS............................................................................................................................................40
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2017-2021 ....................................................................................................42
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2021 (%) ............................................................................43
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2017-2021............................................................................................44
FIGURE 06. HIGH BARGAINING POWER OF BUYERS .......................................................................................................................45
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS ......................................................................................................46
FIGURE 08. HIGH THREAT OF SUBSTITUTION....................................................................................................................................47
FIGURE 09. HIGH THREAT OF NEW ENTRANT ...................................................................................................................................48
FIGURE 10. MODERATE COMPETITIVE RIVALRY...............................................................................................................................49
FIGURE 11. MARKET DYNAMICS .........................................................................................................................................................53
FIGURE 12. APOLLO HOSPITALS: NET SALES, 2018–2020 ($MILLION) ................................................................................... 171
FIGURE 13. APOLLO HOSPITALS: REVENUE SHARE BY SEGMENT, 2020 (%) .......................................................................... 172
FIGURE 14. MEDICOVER: NET SALES, 2018–2020 ($MILLION) ................................................................................................. 190

Global Fertility
FIGURE 15. MEDICOVER: REVENUE SHARE BY SEGMENT, 2020 (%)......................................................................................... 191
Services Market
FIGURE 16. MEDICOVER: REVENUE SHARE BY REGION, 2020 (%) ............................................................................................ 191
and Industry Forecast, FIGURE 17. MVF: NET SALES, 2018–2020 ($MILLION) ............................................................................................................... 194
2020-2027 FIGURE 18. MVF: REVENUE SHARE BY REGION, 2020 (%) .......................................................................................................... 195
FIGURE 19. PROGYNY: NET SALES, 2018–2020 ($MILLION) ..................................................................................................... 198
24
FIGURE 20. PROGYNY: REVENUE SHARE BY SEGMENT, 2020 (%) ............................................................................................ 199
FIGURE 21. VIRTUS HEALTH: NET SALES, 2018–2020 ($MILLION) ........................................................................................... 203
FIGURE 22. VIRTUS HEALTH: REVENUE SHARE BY SEGMENT, 2020 (%) .................................................................................. 204
FIGURE 23. VIRTUS HEALTH: REVENUE SHARE BY REGION, 2020 (%)...................................................................................... 204
Global Fertility
Services Market
2020-2027
25
CHAPTER 1: INTRODUCTION
1.1. Report description
The global fertility services market generated $20,388.61 million in 2019 and is projected to reach $25,709.64
million by 2027, growing at a CAGR of 15.9% from 2020 to 2027.
Fertility services are treatments that assist in treating infertility in patients. In vitro fertilization (IVF), surrogacy,
artificial insemination, and others are different forms of infertility services, which aid couples with infertility
problems, single mothers, and the LGBT community to procreate.
The global fertility services market is expected to witness a substantial growth in the future, owing to high
incidence of infertility cases, emerging trend of delayed pregnancies among women, rise in technological
advancements in fertility procedures, and increased rate of gamete donations. Furthermore, rise in health
awareness on fertility issues, availability of fertility treatments, increase in disposable income, and favorable
reimbursement policies further augment the market growth.
Recent innovations in IVF technology, such as embryoscope and capsule IVF, are projected to boost the demand
for fertility devices in the future. However, strenuous maintenance issues, high cost of devices; multiple
Global Fertility pregnancies, i.e., the delivery of twins, triplets, and others, associated with fertility treatments; and ethical
Services Market considerations are projected to hinder the market growth.
and Industry Forecast, Moreover, rise in new fertility clinics and increase in same-sex marriages are projected to offer lucrative growth
2020-2027 opportunities in future. In addition, rise in fertility tourism is expected to provide ample growth opportunities
especially in the developing economies.
26
The global fertility services market is classified into procedure, service, end user, and region. By procedure, the
market is divided into IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine
insemination (IUI), surrogacy, and others. By service, it is categorized into fresh non-donor, frozen non-donor,
egg & embryo banking, fresh donor, and frozen donor. By end user, the market is segmented into fertility clinics,
hospitals, surgical centers, and clinical research institutes. By region, the market is analyzed across North
America, Europe, Asia-Pacific, and LAMEA.
1.2. Key benefits for stakeholders

 The study provides an in-depth analysis of the fertility services market, and the current trends and
future estimations to elucidate the imminent investment pockets.
 It presents a quantitative analysis of the market from 2019 to 2027 to enable stakeholders to capitalize
on the prevailing market opportunities.
 Extensive analysis of the market based on procedures and services assists to understand the trends in
the industry.
 Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the
market.
Global Fertility
Services Market
2020-2027
27
1.3. Key market segments
By Procedure
 IVF with ICSI
 IUI
 IVF without ICSI
 Surrogacy
 Others
By Service
 Fresh Non-donor
 Frozen Non-donor
 Egg & Embryo Banking
 Fresh Donor
 Frozen Donor
Global Fertility By End User

Services Market  Fertility Clinics
Opportunity Analysis  Hospitals
 Surgical Centers
2020-2027
 Clinical Research Institutes
28
By Region
 North America  Asia-Pacific
o U.S. o Japan
o Canada o India
o Mexico o China
 Europe o Australia
o Germany o South Korea
o France o Rest of Asia-Pacific
o UK  LAMEA
o Italy o Latin America
o Spain o Middle East
o Russia o Africa
o Rest of Europe
Global Fertility
Services Market
2020-2027
29
1.3.1. List of key players profiled in the report
 Apollo Hospitals Enterprise Ltd
 Care Fertility Group Ltd
 Carolinas Fertility Institute
 City Fertility
 Fertility Associates Limited
 Genea Limited
 Medicover Group
 Monash IVF Group Limited
 Progyny Inc.
 Virtus Health
Global Fertility
Services Market
2020-2027
30
1.4. Research methodology
With a collective industry experience of about 200 years of its analysts and experts, Allied Market Research
(AMR) implements the most infallible research methodology for its market intelligence and industry analysis.
Not only does the company dig deep into the innermost levels of the market, but also examines the minutest
details for its market estimates and forecasts.
This approach helps in building a greater, market-specific view for size, shape, and industry trends within each
industry segment. We carefully factor in the industry trends and real developments for identifying key growth
factors and estimate the future course of the market. The research proceeds are the resultant of high-quality
data, expert views and analysis, and high value independent opinions. Our research process is designed to
deliver a balanced view of the global markets and allow stakeholders to make informed decisions to attain their
highest growth objectives.
The company offers its clients exhaustive research and analysis based on wide variety of factual inputs, which
largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house
industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements
of the particular industry segment. These analytical tools and models distill the data & statistics and enhance
Global Fertility the accuracy of our recommendations and advice.
Services Market
2020-2027
31
With AMR’s calibrated research process and 360 degree data-evaluation methodology, the clients are assured
of receiving:
 Consistent, valuable, robust, and actionable data & analysis that can easily be referenced for strategic
business planning.
 Technologically sophisticated and reliable insights through a well-audited and veracious research
methodology.
 Sovereign research proceeds that present a tangible depiction of the marketplace.
This strong research methodology ensures that AMR’s research and analysis is most reliable, and guarantees
sound business planning. For this research report, 18 hours of interviews and discussions have been conducted,
with a wide range of stakeholders, including upstream and downstream participants. Primary research typically
is the bulk of the research efforts; however, it is coherently supported by extensive secondary research. Over
6,100 product literatures, industry releases, annual reports, and other such documents of key industry
participants have been reviewed, for better market understanding and competitive intelligence. In addition,
authentic industry journals, medical journals, trade associations’ releases, and government websites have also
been reviewed for generating high-value industry insights.
Global Fertility
Services Market
2020-2027
32
1.4.1. Secondary research
For the secondary research, a broad array of industry sources is referred, which typically includes, however, are
not limited to:
 Company SEC filings, annual reports, company websites, broker & financial reports and investor
presentations for a competitive scenario and shape of the industry.
 Patent and regulatory databases for understanding of technical & legal developments.
 Scientific and technical Treatment information and related preemptions.
 Regional government and statistical databases for macro-analysis.
 Authentic news articles, web-casts, and other related releases, for market evaluation.
 Internal and external proprietary databases, key market indicators, and relevant press releases for
market estimates and forecast.
1.4.2. Primary research

Primary research efforts include reaching out to participants through mail, tele-conversations, referrals,
professional networks, and face-to-face interactions. Professional corporate relations have been established
Global Fertility with various companies. It allows for greater flexibility in reaching out to industry participants and commentators
Services Market for interviews and discussions, fulfilling the following functions:
Opportunity Analysis  Validate and improve the data quality and strengthen research proceeds
 Further develops analyst team’s market understanding and expertise
2020-2027
 Supplies authentic information about market size, share, growth, and forecast
33
The primary research interview and discussion panels comprise experienced industry personnel. These
participants include, but are not limited to:
 Chief executives and VPs of leading corporations specific to the industry

 Treatment and sales managers or country heads; channel partners and top-level distributors; banking,
investments and valuation experts
 Key opinion leaders (KOLs)
1.4.3. Analyst tools & models

AMR has a developed set of analyst tools and data models to supplement and expedite the analysis process.
Corresponding to the markets where there is significant lack of information and estimates, AMR’s team of
experts and analysts develop specific analyst tools and industry models. These models are used to translate
qualitative and quantitative industry indicators into exact industry estimates. These models also allow them to
examine the prospects and opportunities prevailing in the market to accurately forecast the course of the
market.
Global Fertility
Services Market
2020-2027
34
CHAPTER 2: EXECUTIVE SUMMARY
The global fertility services market generated $20,388.61 million in 2019 and is projected to reach $25,709.64
million by 2027, growing at a CAGR of 15.9% from 2020 to 2027.
Fertility services involve different procedures utilized to treat genetic and fertility issues and assist with
conception. These services include different assisted reproductive technology (ART) methods, helping couples
or single parents around the world. Surge in prevalence of delayed pregnancies and growth in infertility rates
drive the growth of the fertility services industry.
In addition, availability of latest medical technologies in IVF devices throughout the world, is expected to fuel
the fertility services market growth. Fertility services comprising the usage of novel technologies are associated
with higher success rates, for instance, the use of incubators, imaging systems, and software to check the growth
development of embryos. Embryoscope (Create Health) is one such product wherein the embryos can be
monitored without the need of retrieving them out of the incubators, thus helping in selecting the healthy
embryos.
The fertility services market is driven by increase in infertility rates, rise in trend of delayed pregnancies, surge
Global Fertility in ART success rate, and growth in disposable income. Furthermore, rise in prevalence of infertility due to
Services Market increase in risk factors, such as obesity, stress, polycystic ovarian syndrome (PCOS), sexually transmitted
Opportunity Analysis infections, endometrial tuberculosis, and other medical conditions, is expected to offer lucrative opportunities
and Industry Forecast, for the market growth during the forecast period.
2020-2027
35
By procedure, the IVF with ICSI segment accounted for more than half of the market share in fertility services
market in 2019. This segment is expected to exhibit a prominent growth rate, owing to some key factors such
as higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, low
sperm count, and others.
By service, the fresh non-donor segment accounted for major share of the market share in fertility services
market in 2019. This segment is expected to exhibit a prominent growth rate, owing to rapid increase in infertility
rate, technological advancements, and change in lifestyle.
By end user, the fertility clinics segment held 51.93% revenue market share in 2019. This segment is expected
to exhibit a considerable growth rate, owing to delayed pregnancy trends in women, advantages of fresh
embryo transfer over the frozen embryo technique, increase in rate of infertility, and higher success rate of this
technique.
By region, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due
to surge in adoption of fertility procedures, development in the healthcare infrastructure, and rise in fertility
tourism.
Global Fertility
Services Market
2020-2027
36
2.1. Key findings of the study
 By procedure type, the IVF with ICSI segment held 59.11% share in the global fertility services market in
2019.
 By service, the egg and embryo banking segment exhibit fastest growth and is expected to grow at a
CAGR of 18.1% from 2020 to 2027.
 By end user, the fertility clinics segment held largest market share in 2019 and is expected to remain
dominant throughout the forecast period.
 By region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of
18.1% during the forecast period.
2.2. CXO perspective

This section provides the opinions of the top-level CXOs in the fertility services industry. According to the CXOs,
fertility services refer to different assisted reproductive technology procedures undertaken by couples who
cannot conceive naturally.
These services are availed to treat infertility. Different fertility procedures include IVF, IUI, surrogacy, and others.
IVF is one of the most widely known fertility services offered by fertility clinics; this treatment is preferred for
Global Fertility
women with missing or blocked fallopian tubes. In addition, structural causes that cause infertility such as
Services Market
fibroids, endometriosis, cervical problems, and polycystic ovary syndrome also require IVF intervention.
and Industry Forecast, According to the CXOs, the fertility services market is anticipated to witness considerable growth in future,
2020-2027 owing to rise in prevalence of infertility, emerging trend of delayed pregnancies among women, technological
advancements in ART procedures, surge in male infertility, and increased incidence of gamete donations.
37
Moreover, increase in awareness about IVF and surge in popularity of medical & fertility tourism coupled with
advanced ART facilities & treatment options are anticipated to supplement the market growth. However,
inadequate reimbursement policies associated with fertility procedures are expected to impede the market
growth during the forecast period.
The CXOs further state that growth in interest of single parents as well as same-sex couples in experiencing
parenthood through ART and affordable fertility treatment offered in emerging markets such as India are
expected to present lucrative opportunities for the market expansion.
Global Fertility
Services Market
2020-2027
38
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
The report provides market dynamics and trends related to the global fertility services market. In addition, it
presents the market estimations and forecast. The study estimates the revenue generated from the sales of
fertility services. The valuations comprise revenue generated from fertility procedures such as intrauterine
insemination (IUI), IVF with and without intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer
(GIFT), and zygote intrafallopian transfer (ZIFT). This report, however, does not consider the revenue generated
by fertility medications and the costs of other medication involved in fertility treatment.
FIGURE 01. FERTILITY SERVICES MARKET: MARKET SEGMENTATION
BY BY BY BY
PROCEDURE SERVICE END USER REGION
• IVF with ICSI • Fresh Non-donor • Fertility Clinics • North America

Global Fertility • IUI • Frozen Non-donor • Hospitals • Europe
Services Market • IVF without ICSI • Egg & Embryo Banking • Surgical Centers • Asia-Pacific
• Surrogacy • Fresh Donor • Clinical Research • LAMEA
Opportunity Analysis • Others Institutes
• Frozen Donor
2020-2027
Source: Primary Research, Government Publications, Company Releases, and AMR Analysis
39
3.2. Key findings
3.2.1. Top investment pockets
The IVF with ICSI is one of the top investment pockets in the global fertility services market. IVF with ICSI is
expected to grow at a high rate of 16.7%. In addition, the IUI segment is projected to reach $2,016.27 million
by 2027; thereby, growing at a CAGR of 12.0%. IVF with ICSI is one of the most sought-after fertility services
offered by fertility clinics and hospitals. Venture capitalists, IVF specialists, and healthcare professionals
throughout the world focus on development of services that streamline and ease fertility treatment and ART.
The upsurge in male fertility cases throughout the globe due to different lifestyle factors, such as obesity and
stress, has made IVF-ICSI an indispensable technique to treat male infertility. Furthermore, the high success
rates associated with both ICSI-IVF and IUI make them promising segments for investment.
FIGURE 02. TOP INVESTMENT POCKETS

High
Surrogacy
IUI
Others
Market Growth
IVF with ICSI

Global Fertility IVF without ICSI
Services Market
Low
2020-2027
Low Market Attractiveness High
40
3.2.2. Top winning strategies
Top winning strategies are analyzed by performing a thorough study of the leading players in the fertility
services market. Comprehensive analysis of recent developments and growth curves of various companies have
helped in understanding the growth strategies adopted by them and their potential effect on the market. The
companies were evaluated on the basis of annual reports, SEC filings, and press releases. The key strategies
traced from the analysis of recent developments are as follows:
 Business expansion: This strategy is adopted to enhance product portfolio, effective operations, expand
geographical reach, and increase customer base.
 Product launch: Launch of various products help the companies to compete in the market and bring in
new therapies for the treatment of cancer.
 Partnership: This strategy is adopted when two or more companies mutually agree to advance their
interests.
 Acquisition: This move is adopted by companies to expand their geographical presence and cater to
new customers.
Global Fertility
Services Market
2020-2027
41
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2017-2021
3
3
No. of Developments
3
2 2
2
1 1
1
0
2017 2018 2019 2020 2021
Source: Company Website, Annual Report, Secondary Research, and AMR Analysis
Global Fertility
Services Market
2020-2027
42
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2021 (%)
Business expansion
11.1%
11.1% Partnership
44.4%
Collaboration
11.1%
Acquisition
22.2%
Product launch
Global Fertility
Services Market
2020-2027
43
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2017-2021
No. of Developments
3
2 2
1 1 1 1 1 1 1 1
0
Apollo Care City Genea MVF Progyny Virtus
Hospitals Fertility fertility Limited health
Business expansion Partnership Collaboration Acquisition Product launch

Global Fertility
Services Market
2020-2027
44
3.3. Porter’s five force analysis
FIGURE 06. HIGH BARGAINING POWER OF BUYERS
Determinant
Determinant Determinant Impact on Market
Strength
LOW MODERATE HIGH

Number of Buyers HIGH
Purchase Quantity HIGH
Switching Cost MODERATE
Service Dependency LOW
Backward Integration LOW
Global Fertility
Services Market
2020-2027
45
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
Determinant
Strength
LOW MODERATE HIGH

Number of service provider HIGH
Service Differentiation LOW
Service Quality HIGH
Switching Costs MODERATE
Substitute Service MODERATE
Global Fertility
Services Market
2020-2027
46
FIGURE 08. HIGH THREAT OF SUBSTITUTION
Determinant
Strength
LOW MODERATE HIGH

Initial Investment Capital HIGH
Price War MODERATE
Service Quality HIGH
Global Fertility
Services Market
2020-2027
47
FIGURE 09. HIGH THREAT OF NEW ENTRANT
Determinant
Strength
LOW MODERATE HIGH

Investment Cost HIGH
Legal Barriers HIGH
Government Policies HIGH
Global Fertility
Services Market
2020-2027
48
FIGURE 10. MODERATE COMPETITIVE RIVALRY
Determinant
Strength
LOW MODERATE HIGH

Number of Players MODERATE
Exit Barriers HIGH
Strategies MODERATE
Innovation MODERATE
Global Fertility
Services Market
2020-2027
49
3.4. Government regulations
3.4.1. U.S.
There are few attempts made by the federal government to regulate IVF procedures. Some states regulate the
procedure by using medical insurance, and some states have policies that exclude the treatment from the
medical insurance coverage and few with policies including this treatment. The federal government allows
health maintenance organizations (HMOs) who meet federal government criteria to remove/exclude this
treatment from their other basic health services. In the U.S., there are few states, such as Louisiana, New Mexico,
Kentucky, and Illinois, that made direct attempts to regulate the procedure using legislations. The regulations
do not apply for medical use of the treatment for infertility-related problems.
Following are the issues that arise due to this procedure:

 Egg safekeeping
 Egg liability
 Issues of custody over the eggs
 Rights of inheritance of the eggs
 Issues of parentage once the fertilized egg is implanted in the egg donor
Global Fertility  Issues of parentage when donor sperms are used
Services Market  Issues of parentage when donor eggs are used
Opportunity Analysis  Issues of parentage when the fertilized egg is implanted in women other than the egg donor
2020-2027
50
According to Columbia Law School Sexuality & Gender Law Clinic (2016), there are fourteen states in the U.S.
that regulate and permit some form of surrogacy via statute. Even among these states, there is little consistency
in their approach. For example, some surrogacy-friendly states allow compensation, whereas others prohibit it.
In California, there is a law that explicitly allows and regulates full surrogacy contracts only.
This state also allows compensation for the surrogate. Florida, on the other hand, allows both partial and full
surrogacy contracts, but a different law governs each. Both laws allow compensation for the surrogate for
reasonable expenses, and in both types of contracts the intended parents agree to accept custody of and to
assert full parental rights and responsibilities for the child immediately upon the child’s birth.
3.4.2. Europe
With respect to fertility services, different countries in the EU (with the exception of Ireland) now have legislation
regulating ARTs. Most countries supplement their legislation with professional guidelines. Legislation and
regulations have been introduced and modified over the past 30 years. It should be observed that there is no
common regulation with respect to ART in Europe. A framework of different regulations followed in different
countries is observed in Europe for fertility services. Different legislations related to the diverse fertility services
Global Fertility are described below:
Services Market
2020-2027
51
TABLE 01. KEY ART AND FERTILITY SERVICES LEGISLATION IN EUROPE: OVERVIEW
S. No Service Status
Egg donation is not allowed in Germany and Norway. Gamete donation may be anonymous (as for
1 Egg and sperm donation example in France, Italy, Slovenia, and Spain) or non-anonymous (as in the UK, Finland, or Sweden),
where identities are recorded and made available at a later time point to offspring
Not allowed in Austria, Bulgaria, Finland, France, Germany, Hungary, Italy, Lithuania, Norway, Serbia,
2 Surrogacy
Slovakia, Slovenia, Spain, and Sweden
PGD (preimplantation genetic

4 Allowed in most jurisdictions; however, it is still politically controversial in Poland and Lithuania
diagnosis)
5 Embryo freezing It is now allowed in most EU countries; however, it is still contentious in Germany, Italy, and Poland
Genetic embryo screening It is mainly allowed, though with restrictions in Sweden (where PGS is only allowed as part of an
6 (preimplantation genetic ethically approved study), Netherlands (where PGS can be performed at only one national center),
screening, PGS). and France
Source: ESHRE fact sheet (2017)
Global Fertility
Services Market
2020-2027
52
3.5. Market dynamics
The major driving factors of global fertility services market include continuous decline in fertility rates, delayed
pregnancy in women and technological advancements with respect to fertility treatment.
FIGURE 11. MARKET DYNAMICS
DRIVERS
 Continuous decline in fertility
rates
 Delayed pregnancies in women
 Technological advancements
with respect to fertility
treatment
RESTRAINTS OPPORTUNITY
 High treatment costs of ARTs in Rise in fertility tourism

developed countries
Global Fertility  Inadequate reimbursement policies
Services Market
2020-2027
Source: AMR analysis
53
3.5.1. Drivers
3.5.1.1. Continuous decline in fertility rates
Rapid increase in infertility rate is one of the major factors that drive the growth of the fertility services market.
One in every four couples in developing countries is affected by infertility. According to the macrotrends.net
(2019), the global fertility rate across the globe in 2019 was 2.458 births per woman, a 0.41% decline from 2018.
Furthermore, lifestyle habits such as smoking also affect fertility rates in both men and women. For instance,
smoking women have a markedly reduced pregnancy rate. The other lifestyle factors affecting the fertility rates
are stress, nutrition, alcohol, obesity, and others. Rise in infertility rates are not only due to lifestyle changes but
also due to various diseases such as sexually transmitted diseases (STDs) and fertility-related diseases. Hence,
the increase in infertility rates in the near future is anticipated to augment the growth of the market.
3.5.1.2. Delayed pregnancies in women

The trend of delayed pregnancy has steadily increased globally. In older women (more than 40 years), the eggs
produced by the reproductive system are immature for the process of fertilization with male spermatozoa. This
may result in the risk of genetic disorders in the egg. Aging individuals witness a decline in the production of
healthy eggs. Usually few eggs are produced with low quality in older women.
Global Fertility
All this can result in the egg facing risk of genetic disorders. According to the Centers for Disease Control and
Services Market
Prevention (CDC), the rate of pregnancy in the age group of 35–39 years has increased drastically, which further
boosts the growth of the fertility services market.
2020-2027
54
3.5.1.3. Technological advancements with respect to fertility treatment
Fertility services comprising the usage of novel technologies are associated with higher success rates, for
instance, the use of incubators, imaging systems, and software to check the growth development of embryos.
Embryoscope (Create Health) is one such product wherein the embryos can be monitored without the need of
retrieving them out of the incubators, thus helping in selecting the healthy embryos. This equipment also
captures images of the developing embryos continuously. Pre-implantation genetic diagnosis (PGD) is another
technology that aids in the diagnosis of diseases and disorders in the embryos to ensure that the child does
not inherit any disorders.
A new technique known as in vitro maturation, or IVM, takes immature eggs from a woman and grows them in
a lab. When mature, they are fertilized and implanted. The procedure has the potential to help women with
certain ovarian disorders have children, but it is still experimental. Furthermore, freezing of both eggs and sperm
could let service members have children even after an injury to their reproductive organs. Thus, new
advancements help in the improvement of IVF procedures and make handling procedures easy. Thus,
technological advancements cumulatively drive the growth of the fertility services market.
Global Fertility
Services Market
2020-2027
55
3.5.2. Restraints
3.5.2.1. High treatment costs of ARTs in developed countries
Despite the widespread application of fertility services worldwide, the global fertility services market faces a
major limitation in the form of high service costs, especially IVF costs in developed markets. These high costs
are chiefly due to laborious processes in the fertility procedures such as surrogacy and IVF. IVF, for instance,
includes different processes such as egg retrieval, hormone injections, in vitro fertilizations, embryo selections,
and the embryo culture; most of these procedures are high-priced in developed countries. For instance, the ART
treatment costs are estimated to be $15,715 per fresh cycle and $3,812 per frozen cycle in the U.S. Furthermore,
the success rates of conception with first attempt of the IVF cycle are not very promising. Multiple cycles have
to be undertaken by the patient to achieve pregnancy, which considerably adds to the overall cost. These factors
collectively limit the adoption of fertility services in the developed markets.
3.5.2.2. Inadequate reimbursement policies

Health insurance benefits in various countries do not cover the ART procedures. Unavailability of insurance
reimbursements for the IVF treatments impedes the market growth, especially in the developing nations.
Couples cannot afford the high costs of the ART and IVF procedures and hence limit the adoption of such
technologies. According to CDC, 15 states have enacted legislation requiring private insurers to cover some or
Global Fertility
all of the costs of infertility treatments. The type of coverage varies by state, with only eight states mandating
Services Market
reimbursement for assisted reproductive technology (ART). Absence of fixed national reimbursement policies
Opportunity Analysis and plans is the main reason behind these inadequate reimbursements.
2020-2027
56
3.5.3. Opportunity
3.5.3.1. Rise in fertility tourism
Fertility or reproductive tourism is a practice of traveling to other countries for fertility treatments. The key
reasons for the fertility tourism are legal prohibitions, stringent regulations or non-availability of the fertility
procedures in the home country, and the lower costs coupled with technological advancements in the fertility
tourism destinations.
However, it should be noted that different countries have different set of regulations when it comes to fertility
tourism, for instance, Costa Rica recently lifted a 16-year-old ban on IVF. Furthermore, many people especially
Europeans prefer to go to North America for the purpose of fertility tourism as the U.S has a higher success rate
of infertility treatment procedures. Also, because of the presence of liberal regulations, North America is mostly
preferred for fertility tourism.
Moreover, Mexico has become a popular place for fertility tourism, because of the presence of liberal policies
associated with in-vitro fertilization treatment. Israel is the leading place for fertility tourism. India and other
Asian countries are also leading places for some of the infertility treatments. In addition, egg donation is a legal
process in a number of European countries such as Italy and Germany. Thus, many women prefer to go to these
Global Fertility European countries where they can be paid for egg donation. Fertility tourism is anticipated to promote the
Services Market usage of fertility services, especially in emerging markets; thereby, creating lucrative opportunities for the
market growth in the near future.
2020-2027
57
3.6. COVID-19 impact on the fertility services market
The COVID-19 outbreak that started from Wuhan city of China has now spread globally. Almost every nation is
dealing with the outbreak. Most markets are experiencing a decline, owing to the outbreak. This also includes
the fertility services market. The fertility services market is negatively impacted by the pandemic. In addition,
most fertility clinics across the globe have stopped undertaking new cases of infertility treatment for the next
few months, till the condition seems to be under control.
For instance, on March 17, 2020, the American Society for Reproductive Medicine (ASRM) issued certain
recommendations that included not initiating new cycles of assisted ovulation, intrauterine inseminations (IUIs),
in vitro fertilization (IVF), or “non-urgent” egg freezing. Some women have postponed their fertility
consultations, whereas others have delayed their dates of embryo transfer until the pandemic situation ends
and life comes back to normal.
In the ongoing COVID-19 situation, gynecologists are managing antenatal care during pregnancy through
online video sessions to limit exposure to the outside world. However, asymptomatic patients from the U.S.
were able to continue with their initial treatment plan. Most oocyte donation treatments and all embryo
transferences from patients follow the recommended “freeze-all” strategy and later embryo transfer are being
Global Fertility performed under controlled conditions.
Services Market
Moreover, egg donation treatments are canceled and frozen embryos are preserved for later use. Furthermore,
Opportunity Analysis many ongoing pregnancies have been struggling, owing to the disruption caused by COVID-19 pandemic. The
2020-2027 patient treatment schedule has been changed, owing to which the patients have to face huge emotional
dissatisfaction and uncertainty.
58
The ongoing pregnancies by IVF are also struggling for necessary scans and medicines. Thus, factors mentioned
above impact the fertility services market and in turn limit the adoption of fertility services in the developed
markets.
3.7. Number of fertility service centers

Fertility clinics are medical clinics that assist couples, and sometimes individuals, who want to become parents
but for medical reasons have been unable to achieve this goal via the natural course. Furthermore, some of the
methods offered by fertility services centers, include IVF with intracytoplasmic sperm injection (ICSI), surrogacy,
IVF without ICSI, intrauterine insemination (IUI), surrogacy, and others. In addition, as per the rbmojournal.com,
there were 2,500 fertility clinics across the globe from 2008 to 2010.
SR. NO. REGION COUNTRY NO. OF FERTILITY CLINICS YEAR
1 U.S. 450 2020
North America Canada 30 2013
Mexico 31 2014
2 Germany 130 2017
UK 119 2017
Global Fertility Italy 158 2017
Services Market Europe
Spain 238 2017
Opportunity Analysis France 102 2015
2020-2027 Russia 140 2020
3 Asia-Pacific Japan 600 2020
59
SR. NO. REGION COUNTRY NO. OF FERTILITY CLINICS YEAR
China 451 2016
India 400 2018
Australia 86 2020
South Korea More than 14 2020
4 Latin America 175 2015
LAMEA Middle East More than 110 2015
Africa 37 2019
Source: AMR analysis
Global Fertility
Services Market
2020-2027
60
CHAPTER 4: FERTILITY SERVICES MARKET, BY PROCEDURE
4.1. Overview
By procedure, the fertility services market is segmented into:
 IVF with ICSI

 IUI
 IVF without ICSI
 Surrogacy
 Others (GIFT and ZIFT)
The IVF with ICSI segment accounted for the highest market share during the forecast period, in terms of
revenue, owing to the applicability and utility with respect to IVF procedures and high success rates.
Global Fertility
Services Market
2020-2027
61
4.1.1. Market size and forecast
The global fertility services market was valued at $20,388.61 million in 2019 and is projected to reach $25,709.64
million by 2027, growing at a CAGR of 15.9% from 2020 to 2027. IVF with ICSI procedure segment was the
highest contributor to the market with $12,051.36 million in 2019 and is estimated to reach $16,143.00 million
by 2027.
TABLE 02. GLOBAL FERTILITY SERVICES MARKET, BY PROCEDURE, 2019 2027 ($MILLION)
CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 12,051.36 5,462.38 6,657.99 8,317.32 9,681.41 11,124.94 12,703.07 14,359.20 16,143.00 16.7%
IUI 2,075.29 909.78 1,070.77 1,289.34 1,443.86 1,592.90 1,742.32 1,881.95 2,016.27 12.0%
IVF without
5,667.86 2,543.78 3,069.88 3,796.70 4,374.94 4,976.30 5,624.16 6,291.94 7,000.18 15.6%
ICSI
Surrogacy 256.32 112.65 132.93 160.50 180.28 199.57 219.13 237.75 256.06 12.4%
Others 337.78 146.29 170.03 202.12 223.35 243.03 262.05 278.86 294.13 10.5%
Total 20,388.61 9,174.87 11,101.60 13,765.98 15,903.84 18,136.74 20,550.74 23,049.71 25,709.64 15.9%
Global Fertility
Services Market
2020-2027
62
4.2. IVF with ICSI
Intracytoplasmic sperm injection (ICSI) is a specialized form of IVF procedure that is preferably used for the
treatment of severe cases of male infertility, after repeated failed fertilization attempts with conventional IVF, or
after egg freezing (oocyte preservation).
Specialized micromanipulation tools & equipment and inverted microscopes are used to enable embryologists
to select and pick up individual sperm cells in a specially designed ICSI needle. The needle is carefully inserted
through the outer shell of the egg and the egg membrane, and the sperm is injected into the inner part
(cytoplasm) of the egg. This usually results in normal fertilization in around 75–85% of eggs injected with the
sperm cell. Post the manual introduction of sperm cell into the egg, the remaining part of this cycle is similar to
the non-ICSI IVF cycle.
4.2.1. Key market trends, growth factors, and opportunities

Rise in delayed pregnancies in women is the vital factor that boosts the market growth. Also increase in
technological advancements with respect to fertility treatment, surge in success rates associated with ICSI-IVF
in case of poor sperm morphology, poor sperm motility and low sperm count in men, and rise in accessibility
and availability of healthcare facilities, and increase in healthcare and research expenditure are the major factors
Global Fertility drive the growth of the fertility services market. Moreover, rise in technological advancements, surge in
Services Market prevalence of male infertility and modernization in the healthcare sector, and surge in research and
Opportunity Analysis development activities in the healthcare sector further create new opportunities for the market growth during
and Industry Forecast, the forecast period.
2020-2027
63
The Asia-Pacific region was the highest contributor to the IVF with ICSI fertility services market with $5,862.00
million in 2019, and is estimated to reach $9,187.02 million by 2027, registering a CAGR of 19.0% during the
forecast period. This region was also the fastest growing region, registering a CAGR of 19.0% during the forecast
period.
TABLE 03. FERTILITY SERVICES MARKET FOR IVF WITH ICSI, BY REGION, 2019 2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 3,332.22 1,480.72 1,768.54 2,163.77 2,465.43 2,771.67 3,094.56 3,418.34 3,753.21 14.2%
Europe 1,978.04 890.00 1,076.70 1,334.78 1,541.60 1,757.38 1,990.40 2,231.26 2,487.23 15.8%
Asia-Pacific 5,862.00 2,714.00 3,377.35 4,305.44 5,111.82 5,988.89 6,969.20 8,025.09 9,187.02 19.0%
LAMEA 879.10 377.66 435.40 513.33 562.56 607.00 648.91 684.51 715.54 9.6%
Total 12,051.36 5,462.38 6,657.99 8,317.32 9,681.41 11,124.94 12,703.07 14,359.20 16,143.00 16.7%
Global Fertility
Services Market
2020-2027
64
4.3. IUI
Intrauterine insemination (IUI) is an ART procedure wherein the sperm cells are inserted into the woman’s uterus
to facilitate fertilization. This procedure is performed when the woman is ovulating. IUI is a promising fertility
treatment option for women with unexplained infertility, coital disorders, and minimal endometriosis. It is also
beneficial in cases of donor sperm inseminations and mild male factor infertility. IUI success rates may reach as
high as 20% per cycle depending on variables such as age of female, one of the reasons for infertility among
other variables.

With respect to IVF, IUI is an easier procedure to execute. IUI is relatively less invasive and less expensive;
however, the success rates associated with IUI is not very promising. Improvement, regulation, and
standardization of IUI procedures are expected to boost the growth of this technique.
Increase in cases of infertility being reported across developed and developing economies coupled with several
initiatives by government and private organizations for spreading awareness about sexual and reproductive
health are the major factors that drive growth of the global market. In addition, increase in consumption of
various medicines are other major factors are anticipated to boost the growth of the intrauterine insemination
Global Fertility (IUI) market during the forecast period.
Services Market
2020-2027
65
The Asia-Pacific region was the highest contributor to the IUI fertility services market with $958.56 million in
2019 and is estimated to reach $1,044.63 million by 2027. The LAMEA region was the fastest growing region,
registering a CAGR of 14.6% during the forecast period.
TABLE 04. FERTILITY SERVICES MARKET FOR IUI, BY REGION, 2019 2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 484.38 207.52 238.72 280.99 307.66 331.94 355.20 375.49 393.91 9.6%
Europe 535.48 231.42 268.50 318.70 351.82 382.61 412.55 439.31 464.03 10.4%
Asia-Pacific 958.56 427.00 510.42 623.93 708.96 793.25 879.59 962.70 1,044.63 13.6%
LAMEA 96.88 43.84 53.13 65.72 75.43 85.10 94.98 104.46 113.70 14.6%
Total 2,075.29 909.78 1,070.77 1,289.34 1,443.86 1,592.90 1,742.32 1,881.95 2,016.27 12.0%
Global Fertility
Services Market
2020-2027
66
4.4. IVF without ICSI
Non-ICSI IVF refers to conventional IVF cycle, wherein the process does not involve any single spermatozoa
(sperm cell) injection in the oocyte. In this cycle, the sperm cell and eggs are cultured together in a dish, and
the sperm must penetrate the egg on its own, similar to natural insemination, to form an embryo. The embryos
are cultured for nearly 2–6 days in the IVF laboratory. The embryo transfer procedure is performed to place the
embryos in the female uterus.
4.4.1. Key market trends growth factors, and opportunities

Fertility rates are witnessing a continuous decline throughout the world. Estimates from the United Nations
Department of Economic and Social Affairs, World Population Prospects (2017) suggest that the global fertility
rate has declined drastically in the past two decades. Couples seeking parenthood are most likely to choose
conventional IVF treatment to conceive, thereby, creating prospects for the market growth.

The Asia-Pacific region was the highest contributor to the IVF without ICSI fertility services market with $2,788.06
million in 2019 and is estimated to reach $4,022.33 million by 2027. This region was also the fastest growing
region, registering a CAGR of 17.8%.
Global Fertility
Services Market
2020-2027
67
TABLE 05. FERTILITY SERVICES MARKET FOR IVF WITHOUT ICSI, BY REGION, 2019 2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 1,550.98 681.29 804.37 972.84 1,095.77 1,217.76 1,344.06 1,467.70 1,593.05 12.9%
Europe 891.09 396.35 474.01 580.90 663.21 747.37 836.75 927.24 1,021.75 14.5%
Asia-Pacific 2,788.06 1,277.71 1,573.79 1,985.72 2,333.40 2,705.56 3,115.83 3,550.62 4,022.33 17.8%
LAMEA 437.72 188.43 217.70 257.24 282.56 305.61 327.52 346.39 363.05 9.8%
Total 5,667.86 2,543.78 3,069.88 3,796.70 4,374.94 4,976.30 5,624.16 6,291.94 7,000.18 15.6%
4.5. Surrogacy
Surrogacy is a fertility procedure that involves using one woman's uterus for the purpose of implantation and
carrying an embryo to deliver a baby for a couple (intended parents) or another person (single intended parent).
The woman who is supposed to carry the embryo is known as a surrogate. There are two types of surrogacy—
traditional and gestational. Process of surrogacy is complex and includes counselling, psychiatric assessment,
and independent legal advice.
Global Fertility
Services Market 4.5.1. Key market trends, growth factors, and opportunities
The changing regulatory scenario, especially in emerging markets such as India and Mexico, has had a significant
and Industry Forecast, impact on the surrogacy industry. In 2016, the Indian government cleared a draft legislation—Surrogacy Bill
2020-2027
2016—that aimed to ban commercial surrogacy in India. According to this legislation, the intending couple
must be Indian citizens and married for at least five years with at least one of them being infertile. Furthermore,
68
this bill states that the surrogate mother has to be a close relative who has been married and has had a child of
her own. Therefore, the surrogacy regulations in these markets need to be changed to create market
opportunities in the near future.
Moreover, practicing surrogacy is illegal in most of the countries across the globe. Countries including Germany,
Spain, Italy, Japan, and France have banned all forms of surrogacy. Furthermore, India was recognized as the
premiere destination for commercial surrogacy, with more than 3,000 clinics generating an annual collective
revenue of $400 million USD.
However, following exclusionary legislation introduced in 2013, Thailand briefly replaced India as the so-called
womb of Asia until all forms of international surrogacy were banned by the military government in July 2015.
Owing to the barriers encountered in either India or Thailand, countries such as Poland, Ukraine, Russia, Georgia,
Mexico, Nepal, and Cambodia are now emerging as major commercial surrogacy destinations. Therefore, rise
in number of specialty clinics and super specialty IVF with ICSI shows attractive opportunities for the global
market.

The Asia-Pacific region was the highest contributor to the surrogacy fertility services market with $137.39 million
Global Fertility
in 2019 and is estimated to reach $123.70 million by 2027. The LAMEA region was the fastest growing region,
Services Market
2020-2027
69
TABLE 06. FERTILITY SERVICES MARKET FOR SURROGACY, BY REGION, 2019 2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 70.87 31.81 38.37 47.39 54.50 61.83 69.64 77.58 85.89 15.2%
Europe 41.53 18.09 21.15 25.29 28.12 30.80 33.44 35.86 38.13 11.2%
Asia-Pacific 137.39 59.76 69.74 83.23 92.34 100.87 109.21 116.72 123.70 11.0%
LAMEA 6.53 2.99 3.67 4.59 5.32 6.07 6.84 7.59 8.34 15.8%
Total 256.32 112.65 132.93 160.50 180.28 199.57 219.13 237.75 256.06 12.4%
4.6. Others
Other fertility procedures include gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT),
ovulation induction, and others. Ovulation induction is a fertility procedure that involves administration of
hormonal medication; this process is opted by women who cannot ovulate regularly. GIFT is an assisted
reproductive fertility procedure, which involves retrieval of woman’s eggs from her ovaries, mixing them with
sperm, and directly placing them into the fallopian tube. On the other hand, in ZIFT, a fertilized egg is directly
transferred into the fallopian tubes instead of a mixture of sperm and eggs.
Global Fertility
Services Market 4.6.1. Key market trends, growth factors, and opportunities
Opportunity Analysis Other procedures such as GIFT and ZIFT are used to treat different types of infertility problems; however, the
fallopian tubes of the intending mother need to be free from any abnormalities and damage to use this
2020-2027
technique. These techniques can also be used when mild male infertility is observed.
70
These procedures are anticipated to provide lucrative growth opportunities for the market during the forecast
period. Rise in number of patients suffering from problems related to ovulation, uterine problems, blocked
fallopian tubes, poor diet, age, and others boost the market growth during the forecast period. Furthermore,
higher consumption of alcohol, drug abuse, smoking, chemotherapy, radiation therapy, and strong medication
are some of the risk factors causing fertility problems in men. These factors drive the growth of the global
fertility services market.

The Asia-Pacific region was the highest contributor to the other fertility services market with $113.91 million in
2019, and is estimated to reach $119.98 million by 2027. The Asia-Pacific region was also the fastest growing
region, registering a CAGR of 13.1% during the forecast period.
TABLE 07. FERTILITY SERVICES MARKET FOR OTHERS, BY REGION, 2019 2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 84.83 36.42 41.96 49.46 54.19 58.48 62.55 66.05 69.16 9.6%
Europe 91.29 39.24 45.26 53.36 58.47 63.07 67.38 71.01 74.13 9.5%
Global Fertility Asia-Pacific 113.91 50.59 60.28 73.43 83.11 92.59 102.18 111.24 119.98 13.1%
Services Market LAMEA 47.75 20.03 22.52 25.87 27.58 28.89 29.95 30.57 30.86 6.4%
Total 337.78 146.29 170.03 202.12 223.35 243.03 262.05 278.86 294.13 10.5%
and Industry Forecast, Source: Primary Research, Government Publications, Company Releases, and AMR Analysis
2020-2027
71
CHAPTER 5: FERTILITY SERVICES MARKET, BY SERVICE
5.1. Overview
By service, the fertility services market is segmented into:
 Fresh Donor
 Frozen Donor
 Egg & Embryo Banking
 Frozen Non-donor
 Fresh Non-donor
The fresh non-donor service segment dominated the market, in terms of revenue in 2019, and is estimated to
continue this trend during the forecast period due to its preferable use. On the other hand, egg and embryo
banking is anticipated to exhibit the fastest market growth during the forecast period, owing to rise in number
of egg & embryo banking and growth in demand for thaw IVF cycle.
Global Fertility
Services Market
2020-2027
72
The fertility services market was valued at $20,388.61 million in 2019, and is projected to reach $25,709.64
million by 2027, growing at a CAGR of 15.9% from 2020 to 2027. The fresh non-donor segment was the highest
contributor with $11,157.68 million in 2019 and is estimated to reach $14,439.13 million by 2027. The egg and
embryo banking segment is expected to be the fastest growing segment, registering a CAGR of 18.1% during
the forecast period.
TABLE 08. GLOBAL FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-
11,157.68 5,036.61 6,113.50 7,604.91 8,814.29 10,084.62 11,464.60 12,901.64 14,439.13 16.2%
donor
Frozen Non-
4,375.86 1,937.97 2,307.00 2,813.32 3,195.18 3,580.59 3,985.10 4,388.32 4,803.37 13.8%
donor
Egg &
Embryo 2,450.51 1,125.17 1,388.70 1,755.88 2,067.87 2,403.14 2,774.09 3,168.88 3,598.85 18.1%
Banking
Fresh Donor 1,240.62 542.07 636.09 763.97 853.72 940.33 1,027.46 1,109.66 1,189.53 11.9%
Frozen
Global Fertility Donor
1,163.94 533.07 656.31 827.89 972.78 1,128.06 1,299.48 1,481.20 1,678.77 17.8%
Services Market Total 20,388.61 9,174.87 11,101.60 13,765.98 15,903.84 18,136.74 20,550.74 23,049.71 25,709.64 15.9%
2020-2027
73
5.2. Fresh non-donor
In fresh non-donor IVF technique, one or more recently developed embryos from the current cycle of IVF are
transferred into the uterus as soon as they are ready. The fresh embryo IVF cycle begins with the ovarian
stimulation, which is followed by retrieval of all eggs from the patient. These eggs are fertilized to create an
embryo; these embryos are transferred back in the patient. The remaining high-quality embryos are frozen,
which can be used in the future frozen IVF cycles.
Fresh non-donor segment is a major revenue contributor and is estimated to remain dominant during the
forecast period due to preferable use of this technique. Delayed pregnancy trends in women, technological
advancements, advantages of fresh embryo transfer over the frozen embryo technique, increase in rate of
infertility, and higher success rate of this technique are the major drivers of the fresh non-donor segment.

The Asia-Pacific region was the highest contributor to the fresh non-donor fertility services market with
$5,345.29 million in 2019, and is estimated to reach $8,102.12 million by 2027. This region was also the fastest
growing region, registering a CAGR of 18.5% during the forecast period.
Global Fertility
Services Market
2020-2027
74
TABLE 09. FERTILITY SERVICES MARKET FOR FRESH NON-DONOR, BY REGION, 2019-2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 3,038.35 1,346.07 1,602.87 1,955.18 2,221.06 2,489.45 2,771.13 3,051.89 3,340.82 13.9%
Europe 1,966.51 876.69 1,050.88 1,290.87 1,477.28 1,668.75 1,872.87 2,080.52 2,298.29 14.8%
Asia-Pacific 5,345.29 2,464.34 3,053.80 3,876.68 4,583.55 5,347.64 6,197.19 7,106.64 8,102.12 18.5%
LAMEA 807.54 349.50 405.95 482.19 532.40 578.78 623.42 662.60 697.89 10.4%
Total 11,157.68 5,036.61 6,113.50 7,604.91 8,814.29 10,084.62 11,464.60 12,901.64 14,439.13 16.2%
5.3. Frozen non-donor

Frozen non-donor eggs stored through vitrification have shown to eliminate the formation of ice crystals
observed in the slow-freeze cryopreservation process. Vitrified non-donor eggs have also improved success
rates with respect to fertilization.
Lesser stress, lower cost, and convenience offered by the frozen embryo IVF technique fuels its need; thereby,
boosting the growth of the frozen non-donor market. In addition, this technique can be used in women who
Global Fertility
develop cancer after a successful IVF procedure and women who cannot reproduce their own eggs. However,
Services Market
few embryos do not withstand the thawing procedures, and the cryo-damage can adversely affect the quality
of the embryo, which negatively impacts the market growth of this segment.
2020-2027
75
The Asia-Pacific region was the highest contributor to the frozen non-donor fertility services market with
growing region, registering a CAGR of 15.9%.
TABLE 10. FERTILITY SERVICES MARKET FOR FROZEN NON-DONOR, BY REGION, 2019-2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 1,169.28 507.09 590.90 705.13 783.38 858.41 933.85 1,004.75 1,074.11 11.3%
Europe 753.70 331.54 391.95 474.62 535.19 595.39 657.76 718.89 780.88 13.0%
Asia-Pacific 2,142.11 967.68 1,174.49 1,459.67 1,688.83 1,927.21 2,183.40 2,446.54 2,724.00 15.9%
LAMEA 310.77 131.66 149.65 173.90 187.78 199.57 210.09 218.14 224.38 7.9%
Total 4,375.86 1,937.97 2,307.00 2,813.32 3,195.18 3,580.59 3,985.10 4,388.32 4,803.37 13.8%
Global Fertility
Services Market
2020-2027
76
5.4. Egg & embryo banking
Embryos can be banked after hormonal injections in the IVF treatment. Mature eggs are produced through
follicular stimulation using hormonal injections.
This is followed by egg retrieval; these eggs are then fertilized using sperm to form embryos. Alternatively, eggs
can be retrieved from the woman and frozen directly so as to fertilize in the near future. Different fertility clinics
have their specific guidelines for frozen embryo and egg storage after cryopreservation. Egg freezing and
embryo banking are performed for a variety of reasons. These include diagnosis of cancer, premature ovarian
failure, and rapid decline of ovarian function.
The egg and embryo banking segment is estimated to exhibit significant market growth during the forecast
period due to increasing the popularity of egg freezing. Key advantages offered by egg freezing techniques
such as lesser stress, lower cost, and convenience further contribute toward the market growth. On the other
hand, few embryos do not withstand the thawing procedures, and the cryo-damage is expected to hamper the
growth of the egg and embryo banking segment.
Global Fertility
Services Market
2020-2027
77
The Asia-Pacific region was the highest contributor to the egg and embryo banking fertility services market with
growing region, registering a CAGR of 20.3%.
TABLE 11. FERTILITY SERVICES MARKET FOR EGG AND EMBRYO BANKING, BY REGION, 2019-2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 651.75 294.12 356.58 442.65 511.51 582.97 659.59 738.07 820.61 15.8%
Europe 413.27 186.67 226.75 282.28 327.43 374.93 426.59 480.46 538.15 16.3%
Asia-Pacific 1,212.27 568.01 715.06 921.80 1,106.31 1,309.70 1,539.52 1,790.11 2,068.66 20.3%
LAMEA 173.22 76.37 90.31 109.17 122.61 135.54 148.39 160.24 171.42 12.2%
Total 2,450.51 1,125.17 1,388.70 1,755.88 2,067.87 2,403.14 2,774.09 3,168.88 3,598.85 18.1%
Global Fertility
Services Market
2020-2027
78
5.5. Fresh donor
In a fresh donor egg IVF cycle, donor eggs are retrieved and immediately fertilized with the male partner’s
sperm, with the resulting fresh embryos transferred to the recipient. In this cycle, the donor is screened and
matched with prospective parents. Improved fertilization rates are observed in fresh donor IVF services.
Fresh donor egg IVF technique is particularly suitable for older age groups (above 40), in which the egg
production cycle is reduced or stopped. Moreover, this technique is suitable for couples with fertility problems
and for patients who have a history of repeated miscarriages. Donor egg IVF cycles also benefit patients with
genetic diseases by preventing the passage of infected genes to their progeny.
However, the major risk associated with donor egg IVF cycle is multiple pregnancies. Hence, it is necessary to
limit the number of embryos transferred; no more than two or three embryos should be transferred in one day.
Other risks include the possibility of transmission of infectious diseases such as AIDS and other genetic
disorders, owing to the limited screening of the potential egg donors, which limits the use of this technique.
Global Fertility
Services Market
2020-2027
79
The Asia-Pacific region was the highest contributor to the fresh donor fertility services market with $606.03
million in 2019, and is estimated to reach $666.23 million by 2027. The Asia-Pacific region was also the fastest
growing region, registering a CAGR of 13.8% during the forecast period.
TABLE 12. FERTILITY SERVICES MARKET FOR FRESH DONOR, BY REGION, 2019-2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 345.86 147.77 169.51 198.94 217.17 233.57 249.12 262.45 274.34 9.2%
Europe 195.05 84.79 98.96 118.20 131.33 143.80 156.17 167.55 178.41 11.2%
Asia-Pacific 606.03 269.69 322.20 393.84 447.77 501.62 557.31 611.68 666.23 13.8%
LAMEA 93.67 39.82 45.42 52.99 57.45 61.33 64.86 67.97 70.54 8.5%
Total 1,240.62 542.07 636.09 763.97 853.72 940.33 1,027.46 1,109.66 1,189.53 11.9%
Global Fertility
Services Market
2020-2027
80
5.6. Frozen donor
Frozen donor eggs are immediately available for fertilization. Furthermore, the timeline to have the eggs ready
for use is two to three months shorter than fresh eggs during IVF. Frozen donor eggs are affordable when
compared with a traditional fresh donor egg cycle. However, sometimes embryos do not withstand the thawing
procedures, and the cryo-damage can adversely affect the quality of the embryo, which hampers the market
growth.

The Asia-Pacific region was the highest contributor to the frozen donor fertility services market with $554.23
million in 2019, and is estimated to reach $936.65 million by 2027. This region was also the fastest growing
region, registering a CAGR of 20.1%.
TABLE 13. FERTILITY SERVICES MARKET FOR FROZEN DONOR, BY REGION, 2019-2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 318.03 142.72 172.10 212.55 244.43 277.28 312.32 347.99 385.33 15.2%
Europe 208.90 95.41 117.07 147.07 171.98 198.36 227.13 257.25 289.53 17.2%
Global Fertility Asia-Pacific 554.23 259.33 326.04 419.77 503.18 594.98 698.58 811.40 936.65 20.1%
Opportunity Analysis Total 1,163.94 533.07 656.31 827.89 972.78 1,128.06 1,299.48 1,481.20 1,678.77 17.8%
2020-2027
81
CHAPTER 6: FERTILITY SERVICES MARKET, BY END USER
6.1. Overview
By end user, the fertility services market is segmented into:
 Fertility Clinics
 Hospitals
 Surgical Centers
 Clinical Research Centers
The fertility clinics segment accounted for the highest market share in 2019, and this trend is expected to
continue during the forecast period, owing to the availability and accessibility of different services related to
IVF such as infertility treatment, IVF programs, egg donation, sperm donation, intracytoplasmic sperm injection
(ICSI), intracytoplasmic morphologically selected sperm injection (IMSI), and others.
Global Fertility
Services Market
2020-2027
82
The global fertility services market was valued at $20,388.61 million in 2019, and is projected to reach $25,709.64
million by 2027, growing at a CAGR of 15.9% from 2020 to 2027. The fertility clinics segment was the highest
contributor to the global fertility services market with $10,587.87 million in 2019 and is estimated to reach
$12,640.67 million by 2027. The surgical centers segment is expected to be the fastest growing segment,
TABLE 14. GLOBAL FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fertility Clinics 10,587.87 4,733.26 5,689.26 7,007.42 8,040.87 9,107.07 10,247.85 11,413.60 12,640.67 15.1%
Hospitals 5,393.38 2,445.72 2,982.10 3,726.27 4,338.09 4,985.22 5,692.21 6,433.49 7,231.10 16.8%
Surgical Centers 2,255.00 1,045.30 1,301.91 1,660.55 1,971.98 2,310.16 2,687.40 3,092.76 3,537.69 19.0%
Clinical Research
2,152.36 950.60 1,128.32 1,371.74 1,552.90 1,734.28 1,923.28 2,109.86 2,300.18 13.5%
Institutes
Total 20,388.61 9,174.87 11,101.60 13,765.98 15,903.84 18,136.74 20,550.74 23,049.71 25,709.64 15.9%
Source: Primary Research, Company Publications, and AMR Analysis
Global Fertility
Services Market
2020-2027
83
6.2. Fertility clinics
Fertility clinics provide technologically advanced ART treatments to patients suffering from fertility problems.
This sector is the major revenue contributing segment in the fertility services market and is estimated to
dominate the market growth during the forecast period due to availability of a wide range of fertility treatments
under a single roof coupled with improving government reimbursements. Fertility clinics are staffed with skilled
personnel including embryologists, reproductive endocrinologists, nurses, and sonographers. Additional
specialists from hypnotherapy, nutrition, and acupuncture may also be part of the team.
Rise in number of fertility clinics across the globe, coupled with technological advancements, are the factors
expected to boost the growth of the global market during the forecast period. Moreover, awareness among the
people in the developed as well as emerging economies regarding infertility treatment is experiencing a rapid
increase. This has resulted into increased number of fertility treatment clinics worldwide, which is anticipated to
boost the growth of the global market.

The Asia-Pacific region was the highest contributor to the fertility services market for fertility clinics with
$5,155.25 million in 2019 and is estimated to reach $7,170.99 million by 2027. This region was also the fastest
Global Fertility growing region, registering a CAGR of 17.3% during the forecast period.
Services Market
2020-2027
84
TABLE 15. FERTILITY SERVICES MARKET FOR IVF FERTILITY CLINICS, BY REGION, 2019-2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 2,848.05 1,248.45 1,470.89 1,775.14 1,995.07 2,212.28 2,436.21 2,654.21 2,874.18 12.7%
Europe 1,827.67 808.27 960.97 1,170.64 1,328.39 1,487.68 1,655.09 1,822.30 1,994.90 13.8%
Asia Pacific 5,155.25 2,352.40 2,884.87 3,623.82 4,239.11 4,892.68 5,608.34 6,360.67 7,170.99 17.3%
LAMEA 756.89 324.14 372.53 437.82 478.29 514.43 548.20 576.42 600.60 9.2%
Total 10,587.87 4,733.26 5,689.26 7,007.42 8,040.87 9,107.07 10,247.85 11,413.60 12,640.67 15.1%
6.3. Hospitals
Different hospitals provide a variety of fertility treatments for patients worldwide. Alliance with the academic
institutes/universities and availability of government funding are the major factors that drive the growth of the
hospital end user segment. This segment includes the treatment centers that not only provide IVF treatments
but also cater to a wider variety of other treatments that are not related to IVF. Many hospitals provide basic
fertility tests and counselling that require reproductive assisted technology (ART) procedures, especially IVF
Global Fertility intervention.
Services Market
For instance, ART now produces more than 50,000 babies per year in the U.S. via 330,000 IVF procedures, and
and Industry Forecast, demand is growing from the ranks of 7+ million infertile women, many of which delayed childbearing due to
2020-2027 careers. Hence, it is anticipated to boost the demand for fertility services and drives the market growth.
85
The global fertility services market for hospitals accounted for $5,393.38 million in 2019 and is anticipated to
reach $7,231.10 million in 2027, growing with a CAGR of 16.8% from 2020 to 2027. The Asia-Pacific region was
the highest contributor to the fertility services market for hospitals with $2,580.53 million in 2019, and is
estimated to reach $4,054.33 million by 2027.
TABLE 16. FERTILITY SERVICES MARKET FOR HOSPITALS, BY REGION, 2019-2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 1,477.80 657.53 786.31 963.17 1,098.71 1,236.55 1,382.06 1,528.21 1,679.55 14.3%
Europe 942.22 422.16 508.59 627.88 722.17 819.88 924.81 1,032.54 1,146.37 15.3%
Asia Pacific 2,580.53 1,195.28 1,488.04 1,897.66 2,253.82 2,641.28 3,074.40 3,540.94 4,054.33 19.1%
LAMEA 392.83 170.75 199.17 237.56 263.39 287.51 310.93 331.80 350.85 10.8%
Total 5,393.38 2,445.72 2,982.10 3,726.27 4,338.09 4,985.22 5,692.21 6,433.49 7,231.10 16.8%
Global Fertility
Services Market
2020-2027
86
6.4. Surgical centers
Surgical centers offer numerous surgical procedures for the treatment of infertility. For instance, different
surgical sperm removal methods, such as percutaneous epididymal sperm aspiration (PESA), microsurgical
epididymal sperm aspiration (MESA), testicular sperm aspiration (TESA), testicular sperm extraction (TESE), and
others, are provided by surgical centers.

The global fertility services market for surgical centers accounted for $2,255.00 million in 2019 and is anticipated
to reach $ 3,537.69 million in 2027, growing with a CAGR of 19.0% from 2020 to 2027. The Asia-Pacific region
was the highest contributor to the fertility services market for surgical centers with $1,094.25 million in 2019,
and is estimated to reach $1,999.05 million by 2027.
TABLE 17. FERTILITY SERVICES MARKET FOR IVF SURGICAL CENTERS, BY REGION, 2019-2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 612.14 278.91 341.24 427.29 497.85 571.86 651.87 734.65 822.38 16.7%
Europe 385.81 176.40 216.75 272.79 319.69 369.63 424.43 482.16 544.46 17.5%
Global Fertility Asia Pacific 1,094.25 517.53 657.46 855.06 1,035.08 1,235.69 1,464.44 1,716.44 1,999.05 21.3%
Opportunity Analysis Total 2,255.00 1,045.30 1,301.91 1,660.55 1,971.98 2,310.16 2,687.40 3,092.76 3,537.69 19.0%
2020-2027
87
6.5. Clinical research institutes
Clinical research institutes conduct research on different aspects of fertility and reproduction such as increased
number of genetically non-defective and high-quality embryos. Majority of the research on fertility problems
and their possible treatments, including IVF, is performed in clinical research institutes. In addition, technological
advancements in different IVF services, such as ICSI, IMSI, TESE, TESA, and others, drive the growth of the end-
user segment.

The global fertility services market for surgical centers accounted for $2,152.36 million in 2019 and is anticipated
to reach $2,300.18 million in 2027, growing with a CAGR of 13.5% from 2020 to 2027. The Asia-Pacific region
was the highest contributor to the fertility services market for clinical research institutes with $1,029.91 million
in 2019, and is estimated to reach $1,273.30 million by 2027.
TABLE 18. FERTILITY SERVICES MARKET FOR CLINICAL RESEARCH INSTITUTES, BY REGION, 2019-2027 ($MILLION)
CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North America 585.28 252.88 293.53 348.85 385.92 421.00 455.87 488.09 519.11 10.8%
Global Fertility Europe 381.72 168.26 199.30 241.73 272.97 304.03 336.19 367.67 399.53 13.1%
Services Market Asia Pacific 1,029.91 463.86 561.23 695.22 801.62 911.51 1,028.83 1,148.31 1,273.30 15.5%
LAMEA 155.46 65.61 74.27 85.94 92.39 97.74 102.40 105.79 108.25 7.4%
and Industry Forecast, Total 2,152.36 950.60 1,128.32 1,371.74 1,552.90 1,734.28 1,923.28 2,109.86 2,300.18 13.5%
2020-2027
88
CHAPTER 7: FERTILITY SERVICES MARKET, BY REGION
7.1. Overview
The market is analyzed across four key regions:
 North America: This region includes the U.S., Canada, and Mexico.
 Europe: This region includes Germany, France, the UK, Italy, Spain, Russia and rest of Europe.
 Asia-Pacific: This region includes Japan, India, China, Australia, South Korea, and rest of Asia-Pacific.
 LAMEA: This region comprises Latin America, Middle East and Africa.
Asia-Pacific dominated the global fertility services market in 2019, accounting for $9,859.93 million and growing
with a CAGR of 18.1% during the forecast period. This is attributed to increase in awareness & acceptance within
the region for adopting fertility services.
Global Fertility
Services Market
2020-2027
89
The global fertility services market was valued at $20,388.61 million in 2019, and is projected to reach $25,709.64
million by 2027, growing at a CAGR of 15.9% from 2020 to 2027. Asia-Pacific region was the highest contributor
to the global fertility services market with $9,859.93 million in 2019, and is estimated to reach $14,497.67 million
by 2027. This region is also expected to be the fastest growing segment, registering a CAGR of 18.1% during
TABLE 19. GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2019-2027 ($MILLION)

CAGR%
REGION 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
North
5,523.27 2,437.76 2,891.97 3,514.46 3,977.55 4,441.69 4,926.01 5,405.16 5,895.22 13.4%
America
Europe 3,537.42 1,575.10 1,885.61 2,313.03 2,643.22 2,981.23 3,340.52 3,704.66 4,085.26 14.6%
Asia-Pacific 9,859.93 4,529.06 5,591.60 7,071.76 8,329.64 9,681.16 11,176.00 12,766.37 14,497.67 18.1%
LAMEA 1,467.98 632.95 732.43 866.74 953.44 1,032.66 1,108.20 1,173.52 1,231.49 10.0%
Total 20,388.61 9,174.87 11,101.60 13,765.98 15,903.84 18,136.74 20,550.74 23,049.71 25,709.64 15.9%
Global Fertility
Services Market
2020-2027
90
7.2. North America
The North American market is driven by the technological advancements and the wide availability of IVF
reimbursements. The market includes regions such as the U.S., Canada, and Mexico. Mexico has emerged as a
promising fertility destination in the recent years due to the low-cost treatments compared to the U.S. The
fertility services market in the U.S. is anticipated to grow at a steady rate throughout the forecast period.

North America presents productive opportunities for players operating in the fertility services market, owing to
its high population base, growth in knowledge about fertility treatment, rise in popularity of IVF in the U.S,
growth in rate of infertility and practices of embryo banking cycles, technological advancements, and delayed
pregnancy trends.
According to the Centers for Disease Control and Prevention (CDC), the rate of fertilization in the age group of
35 to 39 years through IVF procedure is considerably high. In older women (more than 40 years age group),
eggs produced by reproductive system are not fully formed for the process of fertilization, which result in risk
of genetic disorders in the egg. Moreover, aging individuals experience a decline in production of healthy eggs
and increased chance of miscarriage. Thus, increase in trend of delayed pregnancy in women is anticipated to
Global Fertility drive the growth of the fertility services market.
Services Market
Estimates from Centers for Disease Control and Prevention (CDC) Fertility Clinic Success Rates Report (2018)
suggest that there were approximately 306,197 ART cycles performed at 456 reporting clinics in the U.S. during
2020-2027 2018, resulting in 73,831 live births (deliveries of one or more living infants) and 81,478 live born infants.
91
The CDC estimates further state that although the use of ART is still relatively rare as compared to the potential
demand, its use has doubled over the past decade. Currently, approximately 1.9% of all infants born in the U.S.
every year are conceived using ART. This is anticipated to boost the market growth.
7.2.2. Market size and forecast, by country

The North America fertility services market was valued at $5,523.27 million in 2019, and is projected to reach
$5,895.22 million by 2027, growing at a CAGR of 13.4% from 2020 to 2027. U.S. was the highest contributor to
the North America fertility services market with $5,159.84 million in 2019 and is estimated to reach $5,579.83
million by 2027. Mexico is expected to be the fastest growing region, registering a CAGR of 14.0% during the
forecast period.
TABLE 20. NORTH AMERICA FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
CAGR%
COUNTRY 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
U.S. 5,159.84 2,281.11 2,710.57 3,299.41 3,740.29 4,183.57 4,647.32 5,107.67 5,579.83 13.6%
Canada 266.77 113.78 130.28 152.62 166.26 178.44 189.90 199.59 208.10 9.0%
Mexico 96.66 42.87 51.12 62.43 71.00 79.67 88.79 97.90 107.29 14.0%
Global Fertility Total 5,523.27 2,437.76 2,891.97 3,514.46 3,977.55 4,441.69 4,926.01 5,405.16 5,895.22 13.4%
Services Market Source: Primary Research, Government Publications, Company Releases, and AMR Analysis
2020-2027
92
7.2.3. Market size and forecast, by procedure
The IVF with ICSI segment was the highest contributor to the North America fertility services market with
$3,332.22 million in 2019 and is estimated to reach $3,753.21 million by 2027. The surrogacy segment is
expected to be the fastest growing segment, registering a CAGR of 15.2% during the forecast period.
TABLE 21. NORTH AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 3,332.22 1,480.72 1,768.54 2,163.77 2,465.43 2,771.67 3,094.56 3,418.34 3,753.21 14.2%
IUI 484.38 207.52 238.72 280.99 307.66 331.94 355.20 375.49 393.91 9.6%
IVF without ICSI 1,550.98 681.29 804.37 972.84 1,095.77 1,217.76 1,344.06 1,467.70 1,593.05 12.9%
Surrogacy 70.87 31.81 38.37 47.39 54.50 61.83 69.64 77.58 85.89 15.2%
Others 84.83 36.42 41.96 49.46 54.19 58.48 62.55 66.05 69.16 9.6%
Total 5,523.27 2,437.76 2,891.97 3,514.46 3,977.55 4,441.69 4,926.01 5,405.16 5,895.22 13.4%
Global Fertility
Services Market
2020-2027
93
7.2.4. Market size and forecast, by service
The fresh non-donor segment was the highest contributor to the North America fertility services market with
$3,038.35 million in 2019 and is estimated to reach $3,340.82 million by 2027. The egg and embryo banking
segment is expected to be the fastest growing segment, registering a CAGR of 15.8% during the forecast period.
TABLE 22. NORTH AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 3,038.35 1,346.07 1,602.87 1,955.18 2,221.06 2,489.45 2,771.13 3,051.89 3,340.82 13.9%
Frozen Non-donor 1,169.28 507.09 590.90 705.13 783.38 858.41 933.85 1,004.75 1,074.11 11.3%
Egg & Embryo

651.75 294.12 356.58 442.65 511.51 582.97 659.59 738.07 820.61 15.8%
Banking
Fresh Donor 345.86 147.77 169.51 198.94 217.17 233.57 249.12 262.45 274.34 9.2%
Frozen Donor 318.03 142.72 172.10 212.55 244.43 277.28 312.32 347.99 385.33 15.2%
Total 5,523.27 2,437.76 2,891.97 3,514.46 3,977.55 4,441.69 4,926.01 5,405.16 5,895.22 13.4%
Global Fertility
Services Market
2020-2027
94
7.2.5. Market size and forecast, by end user
The fertility clinics segment was the highest contributor to the North America fertility services market with
$2,848.05 million in 2019 and is estimated to reach $2,874.18 million by 2027. The surgical centers segment is
TABLE 23. NORTH AMERICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 1,477.80 657.53 786.31 963.17 1,098.71 1,236.55 1,382.06 1,528.21 1,679.55 14.3%
Surgical Centers 612.14 278.91 341.24 427.29 497.85 571.86 651.87 734.65 822.38 16.7%
Clinical Research
585.28 252.88 293.53 348.85 385.92 421.00 455.87 488.09 519.11 10.8%
Institutes
Total 5,523.27 2,437.76 2,891.97 3,514.46 3,977.55 4,441.69 4,926.01 5,405.16 5,895.22 13.4%
Global Fertility
Services Market
2020-2027
95
7.2.5.1. U.S. market size and forecast, by procedure
The U.S. fertility services market accounted for $5,159.84 million in 2019 and is expected to reach $5,579.83
million by 2027, growing at a CAGR of 13.6% during the forecast period. The IVF with ICSI segment was the
highest contributor to the U.S. fertility services market with $3,130.99 million in 2019 and is estimated to reach
$3,579.46 million by 2027. The surrogacy segment is expected to be the fastest growing segment, registering a
CAGR of 15.8% during the forecast period.
TABLE 24. U.S. FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 3,130.99 1,394.07 1,668.29 2,045.02 2,334.50 2,629.32 2,940.94 3,254.42 3,579.46 14.4%
IUI 434.46 185.97 213.73 251.33 274.91 296.30 316.72 334.42 350.41 9.5%
IVF without ICSI 1,456.62 640.93 758.01 918.31 1,036.06 1,153.31 1,274.99 1,394.52 1,516.04 13.1%
Surrogacy 61.92 27.94 33.88 42.07 48.62 55.43 62.74 70.23 78.12 15.8%
Others 75.85 32.19 36.66 42.69 46.19 49.21 51.93 54.08 55.80 8.2%
Total 5,159.84 2,281.11 2,710.57 3,299.41 3,740.29 4,183.57 4,647.32 5,107.67 5,579.83 13.6%
Global Fertility
Services Market
2020-2027
96
7.2.5.2. U.S. Market size and forecast, by service
The fresh non-donor segment was the highest contributor to the U.S. fertility services market with $2,838.43
million in 2019 and is estimated to reach $3,162.09 million by 2027. The egg and embryo banking segment is
TABLE 25. U.S. FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 2,838.43 1,259.57 1,502.33 1,835.55 2,088.58 2,344.79 2,614.35 2,883.92 3,162.09 14.1%
Frozen Non-donor 1,092.34 474.50 553.84 661.99 736.65 808.53 881.02 949.45 1,016.64 11.5%
Egg & Embryo

608.86 275.22 334.21 415.56 481.00 549.09 622.28 697.45 776.71 16.0%
Banking
Fresh Donor 323.01 138.15 158.64 186.38 203.66 219.27 234.11 246.89 258.35 9.4%
Frozen Donor 297.21 133.67 161.55 199.94 230.40 261.89 295.57 329.96 366.04 15.5%
Total 5,159.84 2,281.11 2,710.57 3,299.41 3,740.29 4,183.57 4,647.32 5,107.67 5,579.83 13.6%
Global Fertility
Services Market
2020-2027
97
7.2.5.3. U.S. Market size and forecast, by end user
The fertility clinics segment was the highest contributor to the U.S. fertility services market with $2,660.42 million
in 2019 and is estimated to reach $2,721.28 million by 2027. The surgical centers segment is expected to be the
fastest growing segment, registering a CAGR of 16.9% during the forecast period.
TABLE 26. U.S. FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 1,380.77 615.36 737.07 904.33 1,033.25 1,164.76 1,303.92 1,444.13 1,589.69 14.5%
Clinical Research
546.43 236.44 274.85 327.14 362.43 395.97 429.41 460.46 490.47 11.0%
Institutes
Total 5,159.84 2,281.11 2,710.57 3,299.41 3,740.29 4,183.57 4,647.32 5,107.67 5,579.83 13.6%
Global Fertility
Services Market
2020-2027
98
7.2.5.4. Canada size and forecast, by procedure
The IVF with ICSI segment was the highest contributor to the Canada fertility services market with $167.48
million in 2019 and is estimated to reach $129.11 million by 2027. The others segment is expected to be the
fastest growing segment, registering a CAGR of 24.5% during the forecast period.
TABLE 27. CANADA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 167.48 71.33 81.55 95.39 103.76 111.20 118.16 124.01 129.11 8.8%
IUI 11.52 4.97 5.75 6.80 7.48 8.11 8.72 9.25 9.74 10.1%
IVF without ICSI 77.92 32.97 37.46 43.53 47.04 50.07 52.85 55.09 56.96 8.1%
Surrogacy 7.50 3.23 3.74 4.43 4.87 5.28 5.68 6.03 6.35 10.1%
Others 2.35 1.28 1.79 2.48 3.11 3.78 4.49 5.21 5.95 24.5%
Total 266.77 113.78 130.28 152.62 166.26 178.44 189.90 199.59 208.10 9.0%
Global Fertility
Services Market
2020-2027
99
7.2.5.5. Canada Market size and forecast, by service
The fresh non-donor segment was the highest contributor to the Canada fertility services market with $146.75
million in 2019 and is estimated to reach $117.93 million by 2027. The egg and embryo banking segment is
TABLE 28. CANADA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 146.75 62.83 72.21 84.90 92.84 100.01 106.83 112.69 117.93 9.4%
Frozen Non-donor 56.48 23.67 26.62 30.62 32.75 34.49 36.00 37.10 37.92 7.0%
Egg & Embryo

31.48 13.73 16.06 19.22 21.38 23.42 25.43 27.25 28.97 11.3%
Banking
Fresh Donor 16.81 7.03 7.88 9.04 9.64 10.13 10.54 10.83 11.03 6.7%
Frozen Donor 15.26 6.53 7.51 8.83 9.65 10.40 11.10 11.71 12.26 9.4%
Total 266.77 113.78 130.28 152.62 166.26 178.44 189.90 199.59 208.10 9.0%
Global Fertility
Services Market
2020-2027
100
7.2.5.6. Canada Market size and forecast, by end user
The fertility clinics segment was the highest contributor to the Canada fertility services market with $137.42
million in 2019 and is estimated to reach $100.58 million by 2027. The surgical centers segment is expected to
be the fastest growing segment, registering a CAGR of 12.1% during the forecast period.
TABLE 29. CANADA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fertility Clinics 137.42 58.16 66.07 76.79 83.00 88.37 93.29 97.25 100.58 8.1%
Hospitals 71.39 30.69 35.43 41.83 45.93 49.68 53.28 56.43 59.29 9.9%
Clinical Research
28.38 11.91 13.40 15.43 16.52 17.41 18.20 18.77 19.21 7.1%
Institutes
Total 266.77 113.78 130.28 152.62 166.26 178.44 189.90 199.59 208.10 9.0%
Global Fertility
Services Market
2020-2027
101
7.2.5.7. Mexico market size and forecast, by procedure
The Mexico fertility services market accounted for $96.66 million in 2019 and is expected to reach $107.29
highest contributor to the Mexico fertility services market with $33.74 million in 2019 and is estimated to reach
$44.64 million by 2027. This segment is also expected to be the fastest growing segment, registering a CAGR
of 16.5% during the forecast period.
TABLE 30. MEXICO FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 33.74 15.33 18.70 23.36 27.16 31.15 35.46 39.92 44.64 16.5%
IUI 38.39 16.59 19.25 22.86 25.27 27.53 29.77 31.81 33.75 10.7%
IVF without ICSI 16.43 7.38 8.91 11.01 12.67 14.39 16.22 18.09 20.05 15.4%
Surrogacy 1.46 0.64 0.75 0.90 1.01 1.11 1.22 1.32 1.43 12.2%
Others 6.63 2.94 3.51 4.29 4.89 5.49 6.12 6.76 7.41 14.1%
Total 96.66 42.87 51.12 62.43 71.00 79.67 88.79 97.90 107.29 14.0%
Global Fertility
Services Market
2020-2027
102
7.2.5.8. Mexico Market size and forecast, by service
The fresh non-donor segment was the highest contributor to the Mexico fertility services market with $53.17
million in 2019 and is estimated to reach $60.80 million by 2027. The egg and embryo banking segment is
TABLE 31. MEXICO FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 53.17 23.67 28.33 34.73 39.65 44.65 49.95 55.28 60.80 14.4%
Frozen Non-donor 20.46 8.92 10.44 12.52 13.98 15.40 16.83 18.20 19.55 11.9%
Egg & Embryo

11.41 5.17 6.30 7.86 9.13 10.46 11.89 13.37 14.94 16.4%
Banking
Fresh Donor 6.05 2.60 2.99 3.53 3.87 4.18 4.47 4.73 4.97 9.7%
Frozen Donor 5.57 2.51 3.05 3.78 4.37 4.99 5.65 6.32 7.04 15.9%
Total 96.66 42.87 51.12 62.43 71.00 79.67 88.79 97.90 107.29 14.0%
Global Fertility
Services Market
2020-2027
103
7.2.5.9. Mexico Market size and forecast, by end user
The fertility clinics segment was the highest contributor to the Mexico fertility services market with $50.22
million in 2019 and is estimated to reach $52.33 million by 2027. The surgical centers segment is expected to
be the fastest growing segment, registering a CAGR of 17.8% during the forecast period.
TABLE 32. MEXICO FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 25.63 11.48 13.81 17.02 19.53 22.11 24.86 27.65 30.57 15.0%
Clinical Research
10.47 4.53 5.28 6.28 6.97 7.61 8.26 8.86 9.43 11.0%
Institutes
Total 96.66 42.87 51.12 62.43 71.00 79.67 88.79 97.90 107.29 14.0%
Global Fertility
Services Market
2020-2027
104
7.3. Europe
Europe is studied across the UK, Germany, France, Spain, Italy, and rest of Europe. Europe leads the global
artificial reproductive techniques (ART) market, initiating maximum treatment cycles. The European IVF market
is driven by the favorable government policies regarding IVF and availability of fertility services. There are
various reasons for infertility, which include physiological, genetically induced disorders and at times may be
self-induced as in the case of contraceptive surgeries. The key factors driving the Europe fertility services market
include rise in awareness among couples about various infertility treatments, low-cost treatment options and,
an increase in new options for infertility treatment such as surrogacy. Furthermore, availability of
reimbursements has increased the adoption of IVF procedures in Europe. According to the European Society of
Human Reproduction and Embryology, EU member states are free to enact their own medical legislations, as
patients in Europe have freedom of movement for treatment (under a 2008 European Commission directive).

Europe houses 40% of the world’s IVF clinics, and this has proved to be a major contributory factor for the
European infertility testing and treatment market’s success. The region has also witnessed substantial
investments from global market leaders. The overall outlook for the European market looks promising as its
superior IVF technology is attracting considerable investments from private equity investors. Also, DIY testing
Global Fertility
has increased the access and helped in reducing the costs for infertility testing and treatment. Both these factors
Services Market
are providing lucrative opportunities for fertility services market growth. Different fertility and ART services are
allowed and disallowed in EU countries. For instance, egg donation is not allowed in Germany and Norway,
2020-2027 whereas preimplantation genetic diagnosis (PGD) is allowed in most jurisdictions but is still controversial in
Lithuania and Poland.
105
7.3.2. Europe Market size and forecast, by country
The Europe fertility services market was valued at $3,537.42 million in 2019, and is projected to reach $4,085.26
million by 2027, growing at a CAGR of 14.6% from 2020 to 2027. Spain was the highest contributor to the
Europe fertility services market with $855.35 million in 2019 and is estimated to reach $1,156.54 million by 2027.
The Spain is expected to be the fastest growing country registering a CAGR of 16.8% during the forecast period.
TABLE 33. EUROPE FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)

CAGR%
COUNTRY 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Germany 453.14 202.03 242.16 297.43 340.31 384.32 431.18 478.78 528.63 14.7%
France 236.30 102.62 119.74 143.06 159.12 174.55 190.08 204.68 218.97 11.4%
UK 572.00 247.55 287.79 342.53 379.43 414.43 449.22 481.37 512.29 10.9%
Italy 341.36 145.74 166.97 195.62 213.04 228.44 242.69 254.42 264.32 8.9%
Spain 855.35 388.99 475.41 595.11 693.71 797.81 911.21 1,029.67 1,156.54 16.8%
Russia 565.28 267.59 339.36 439.62 529.04 626.77 736.00 853.60 982.51 20.4%
Rest of Europe 513.99 220.59 254.18 299.65 328.55 354.91 380.15 402.14 422.01 9.7%
Services Market Source: Primary Research, Government Publications, Company Releases, and AMR Analysis
2020-2027
106
7.3.3. Europe Market size and forecast, by procedure
million by 2027, growing at a CAGR of 14.6% from 2020 to 2027. The IVF with ICSI segment was the highest
contributor to the Europe fertility services market with $1,978.04 million in 2019 and is estimated to reach
$2,487.23 million by 2027.
TABLE 34. EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 1,978.04 890.00 1,076.70 1,334.78 1,541.60 1,757.38 1,990.40 2,231.26 2,487.23 15.8%
IUI 535.48 231.42 268.50 318.70 351.82 382.61 412.55 439.31 464.03 10.4%
IVF without ICSI 891.09 396.35 474.01 580.90 663.21 747.37 836.75 927.24 1,021.75 14.5%
Surrogacy 41.53 18.09 21.15 25.29 28.12 30.80 33.44 35.86 38.13 11.2%
Others 91.29 39.24 45.26 53.36 58.47 63.07 67.38 71.01 74.13 9.5%
Total 3,537.42 1,575.10 1,885.61 2,313.03 2,643.22 2,981.23 3,340.52 3,704.66 4,085.26 14.6%
Global Fertility
Services Market
2020-2027
107
7.3.4. Europe market size and forecast, by service
$2,298.29 million by 2027, growing with a CAGR of 14.8% during the forecast period.
TABLE 35. EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 1,966.51 876.69 1,050.88 1,290.87 1,477.28 1,668.75 1,872.87 2,080.52 2,298.29 14.8%
Frozen Non-donor 753.70 331.54 391.95 474.62 535.19 595.39 657.76 718.89 780.88 13.0%
Egg & Embryo

413.27 186.67 226.75 282.28 327.43 374.93 426.59 480.46 538.15 16.3%
Banking
Fresh Donor 195.05 84.79 98.96 118.20 131.33 143.80 156.17 167.55 178.41 11.2%
Frozen Donor 208.90 95.41 117.07 147.07 171.98 198.36 227.13 257.25 289.53 17.2%
Total 3,537.42 1,575.10 1,885.61 2,313.03 2,643.22 2,981.23 3,340.52 3,704.66 4,085.26 14.6%
Global Fertility
Services Market
2020-2027
108
7.3.5. Europe market size and forecast, by end user
$1,994.90 million by 2027, growing with a CAGR of 13.8% during the forecast period.
TABLE 36. EUROPE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fertility Clinics 1,827.67 808.27 960.97 1,170.64 1,328.39 1,487.68 1,655.09 1,822.30 1,994.90 13.8%
Hospitals 942.22 422.16 508.59 627.88 722.17 819.88 924.81 1,032.54 1,146.37 15.3%
Clinical Research
381.72 168.26 199.30 241.73 272.97 304.03 336.19 367.67 399.53 13.1%
Institutes
Total 3,537.42 1,575.10 1,885.61 2,313.03 2,643.22 2,981.23 3,340.52 3,704.66 4,085.26 14.6%
Global Fertility
Services Market
2020-2027
109
7.3.5.1. Germany market size and forecast, by procedure
The Germany fertility services market accounted for $453.14 million in 2019, and is expected to reach $528.63
million by 2027, growing at a CAGR of 14.7% during the forecast period. The Germany IVF with ICSI market was
valued at $266.27 million in 2019, and is projected to reach $333.20 million by 2027, growing at a CAGR of
15.7% from 2020 to 2027. In addition, practicing all forms of surrogacy is banned in Germany.
TABLE 37. GERMANY FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 266.27 119.79 144.88 179.53 207.23 236.08 267.17 299.22 333.20 15.7%
IUI 54.29 23.36 26.99 31.92 35.10 38.04 40.89 43.41 45.73 10.1%
IVF without ICSI 123.16 54.83 65.63 80.48 91.95 103.69 116.16 128.79 141.99 14.6%
Surrogacy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 9.43 4.05 4.66 5.49 6.02 6.50 6.96 7.36 7.72 9.7%
Total 453.14 202.03 242.16 297.43 340.31 384.32 431.18 478.78 528.63 14.7%
Global Fertility
Services Market
2020-2027
110
7.3.5.2. Germany market size and forecast, by service
The Europe fertility services market was valued at $453.14 million in 2019, and is projected to reach $528.63
contributor to the Germany fertility services market with $303.02 million in 2019 and is estimated to reach
$352.18 million by 2027, growing with a CAGR of 14.7% during the forecast period. Egg donation practicing is
banned in Germany.
TABLE 38. GERMANY FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 303.02 135.03 161.78 198.61 227.14 256.39 287.52 319.11 352.18 14.7%
Frozen Non-donor 97.83 43.60 52.24 64.14 73.35 82.81 92.86 103.08 113.76 14.7%
Egg & Embryo

52.29 23.39 28.14 34.68 39.82 45.12 50.79 56.59 62.70 15.1%
Banking
Fresh Donor 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Frozen Donor 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total 453.14 202.03 242.16 297.43 340.31 384.32 431.18 478.78 528.63 14.7%
Global Fertility Source: Primary Research, Government Publications, Company Releases, and AMR Analysis
Services Market
2020-2027
111
7.3.5.3. Germany market size and forecast, by end user
The Germany fertility services market was valued at $453.14 million in 2019, and is projected to reach $528.63
contributor to the Germany fertility services market with $233.64 million in 2019 and is estimated to reach
$257.81 million by 2027, growing with a CAGR of 13.9% during the forecast period.
TABLE 39. GERMANY FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 120.72 54.03 65.03 80.18 92.11 104.42 117.61 131.11 145.32 15.2%
Clinical Research
50.07 22.70 27.65 34.52 40.12 46.02 52.43 59.11 66.24 16.5%
Institutes
Total 453.14 202.03 242.16 297.43 340.31 384.32 431.18 478.78 528.63 14.7%
Global Fertility
Services Market
2020-2027
112
7.3.5.4. France market size and forecast, by procedure
The France fertility services market accounted for $236.30 million in 2019, and is expected to reach $218.97
highest contributor to the France fertility services market with $108.82 million in 2019 and is estimated to reach
$107.49 million by 2027. Surrogacy in all forms is banned in France.
TABLE 40. FRANCE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 108.82 47.65 56.05 67.51 75.69 83.70 91.86 99.70 107.49 12.3%
IUI 67.63 29.09 33.62 39.77 43.81 47.58 51.29 54.68 57.90 10.3%
IVF without ICSI 48.04 20.81 24.22 28.86 32.02 35.04 38.06 40.88 43.62 11.2%
Surrogacy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 11.81 5.07 5.85 6.91 7.60 8.24 8.86 9.43 9.96 10.1%
Total 236.30 102.62 119.74 143.06 159.12 174.55 190.08 204.68 218.97 11.4%
Global Fertility
Services Market
2020-2027
113
7.3.5.5. France market size and forecast, by service
The France fertility services market was valued at $236.30 million in 2019, and is projected to reach $218.97
contributor to the France fertility services market with $129.66 million in 2019 and is estimated to reach $121.79
million by 2027, growing with a CAGR of 11.6% during the forecast period.
TABLE 41. FRANCE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 129.66 56.40 65.92 78.90 87.91 96.59 105.36 113.65 121.79 11.6%
Frozen Non-donor 50.76 21.94 25.47 30.28 33.52 36.59 39.65 42.48 45.22 10.9%
Egg & Embryo

27.22 11.84 13.84 16.57 18.46 20.28 22.12 23.87 25.58 11.6%
Banking
Fresh Donor 15.26 6.60 7.67 9.13 10.11 11.05 11.98 12.85 13.69 11.0%
Frozen Donor 13.40 5.84 6.83 8.18 9.13 10.04 10.96 11.84 12.70 11.8%
Total 236.30 102.62 119.74 143.06 159.12 174.55 190.08 204.68 218.97 11.4%
Global Fertility
Services Market
2020-2027
114
7.3.5.6. France market size and forecast, by end user
The fertility clinics segment was the highest contributor to the France fertility services market with $122.19
million in 2019 and is estimated to reach $109.31 million by 2027, growing with a CAGR of 10.9% during the
forecast period.
TABLE 42. FRANCE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 62.88 27.39 32.05 38.40 42.84 47.12 51.46 55.58 59.63 11.8%
Clinical Research
25.78 11.28 13.25 15.94 17.85 19.72 21.62 23.44 25.25 12.2%
Institutes
Total 236.30 102.62 119.74 143.06 159.12 174.55 190.08 204.68 218.97 11.4%
Global Fertility
Services Market
2020-2027
115
7.3.5.7. UK market size and forecast, by procedure
The UK fertility services market was valued at $572.00 million in 2019, and is projected to reach $512.29 million
by 2027, growing at a CAGR of 10.9% from 2020 to 2027. The IVF with ICSI segment was the highest contributor
to the UK fertility services market with $343.94 million in 2019 and is estimated to reach $324.23 million by
2027.
TABLE 43. UK FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 343.94 149.83 175.32 210.02 234.15 257.38 280.76 302.76 324.23 11.7%
IUI 68.24 28.97 33.03 38.54 41.83 44.75 47.49 49.80 51.84 8.7%
IVF without ICSI 145.69 62.78 72.68 86.14 95.01 103.33 111.52 118.98 126.08 10.5%
Surrogacy 1.83 0.78 0.88 1.03 1.12 1.20 1.27 1.33 1.38 8.6%
Others 12.30 5.19 5.87 6.80 7.32 7.77 8.18 8.50 8.76 7.8%
Total 572.00 247.55 287.79 342.53 379.43 414.43 449.22 481.37 512.29 10.9%
Global Fertility
Services Market
2020-2027
116
7.3.5.8. UK market size and forecast, by service
by 2027, growing at a CAGR of 10.9% from 2020 to 2027. The fresh non-donor segment was the highest
contributor to the UK fertility services market with $314.66 million in 2019 and is estimated to reach $290.32
million by 2027, growing at a CAGR of 11.4% during the forecast period.
TABLE 44. UK FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 314.66 136.69 159.51 190.56 211.88 232.28 252.71 271.80 290.32 11.4%
Frozen Non-donor 121.09 51.49 58.80 68.72 74.73 80.09 85.16 89.48 93.34 8.9%
Egg & Embryo

67.50 29.87 35.48 43.14 48.80 54.39 60.15 65.73 71.31 13.2%
Banking
Fresh Donor 35.81 14.99 16.84 19.35 20.66 21.72 22.63 23.27 23.72 6.8%
Frozen Donor 32.95 14.51 17.15 20.76 23.37 25.94 28.57 31.10 33.61 12.8%
Total 572.00 247.55 287.79 342.53 379.43 414.43 449.22 481.37 512.29 10.9%
Global Fertility
Services Market
2020-2027
117
7.3.5.9. UK market size and forecast, by end user
by 2027, growing at a CAGR of 10.9% from 2020 to 2027. The fertility clinics segment was the highest contributor
to the UK fertility services market with $294.92 million in 2019 and is estimated to reach $249.84 million by
2027, growing with a CAGR of 10.2% during the forecast period.
TABLE 45. UK FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)

CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 153.07 66.78 78.26 93.88 104.82 115.38 126.04 136.10 145.95 11.8%
Clinical Research
60.57 25.66 29.18 33.96 36.77 39.23 41.51 43.40 45.03 8.4%
Institutes
Total 572.00 247.55 287.79 342.53 379.43 414.43 449.22 481.37 512.29 10.9%
Global Fertility
Services Market
2020-2027
118
7.3.5.10. Italy market size and forecast, by procedure
The Italy fertility services market was valued at $341.36 million in 2019, and is projected to reach $264.32 million
by 2027, growing at a CAGR of 8.9% from 2020 to 2027. The IVF with ICSI segment was the highest contributor
to the Italy fertility services market with $164.64 million in 2019 and is estimated to reach $131.68 million by
2027, growing at a CAGR of 9.3% during the forecast period.
TABLE 46. ITALY FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 164.64 70.58 81.19 95.52 104.44 112.44 119.94 126.25 131.68 9.3%
IUI 70.08 29.94 34.32 40.23 43.83 47.03 49.99 52.43 54.50 8.9%
IVF without ICSI 85.00 36.16 41.29 48.21 52.32 55.91 59.19 61.84 64.02 8.5%
Surrogacy 14.10 5.85 6.52 7.41 7.83 8.14 8.37 8.48 8.51 5.5%
Others 7.54 3.20 3.65 4.26 4.61 4.92 5.20 5.42 5.60 8.3%
Total 341.36 145.74 166.97 195.62 213.04 228.44 242.69 254.42 264.32 8.9%
Global Fertility
Services Market
2020-2027
119
7.3.5.11. Italy Market size and forecast, by service
The fresh non-donor segment was the highest contributor to the Italy fertility services market with $187.78
million in 2019 and is estimated to reach $149.79 million by 2027, growing at a CAGR of 9.3% during the forecast
period. Frozen donor segment is anticipated to grow at the fastest CAGR of 10.1% during the forecast period.
TABLE 47. ITALY FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 187.78 80.47 92.54 108.83 118.96 128.03 136.52 143.65 149.79 9.3%
Frozen Non-donor 72.71 30.66 34.70 40.14 43.16 45.69 47.91 49.56 50.80 7.5%
Egg & Embryo

39.46 16.93 19.49 22.95 25.12 27.06 28.89 30.43 31.77 9.4%
Banking
Fresh Donor 21.85 9.22 10.44 12.09 13.02 13.79 14.48 14.99 15.38 7.6%
Frozen Donor 19.56 8.45 9.79 11.61 12.78 13.86 14.89 15.78 16.57 10.1%
Total 341.36 145.74 166.97 195.62 213.04 228.44 242.69 254.42 264.32 8.9%
Global Fertility
Services Market
2020-2027
120
7.3.5.12. Italy market size and forecast, by end user
The fertility clinics segment was the highest contributor to the Italy fertility services market with $176.01 million
in 2019 and is estimated to reach $128.91 million by 2027, growing with a CAGR of 8.1% during the forecast
period. Surgical centers is anticipated to grow at the fastest rate of 12.0% during the forecast period.
TABLE 48. ITALY FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 91.25 39.22 45.25 53.38 58.52 63.17 67.56 71.30 74.56 9.6%
Clinical Research
36.25 15.19 17.09 19.64 20.97 22.05 22.95 23.57 23.97 6.7%
Institutes
Total 341.36 145.74 166.97 195.62 213.04 228.44 242.69 254.42 264.32 8.9%
Global Fertility
Services Market
2020-2027
121
7.3.5.13. Spain market size and forecast, by procedure
The Spain fertility services market was valued at $855.35 million in 2019, and is projected to reach $1,156.54
contributor to the Spain fertility services market with $529.80 million in 2019 and is estimated to reach $762.16
million by 2027.
TABLE 49. SPAIN FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 529.80 242.87 299.17 377.45 443.42 513.91 591.47 673.45 762.16 17.7%
IUI 79.46 34.83 40.97 49.28 55.12 60.70 66.27 71.42 76.33 11.9%
IVF without ICSI 231.46 104.97 127.93 159.70 185.64 212.90 242.47 273.22 306.02 16.5%
Surrogacy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 14.63 6.33 7.33 8.68 9.54 10.30 11.00 11.57 12.03 9.6%
Total 855.35 388.99 475.41 595.11 693.71 797.81 911.21 1,029.67 1,156.54 16.8%
Global Fertility
Services Market
2020-2027
122
7.3.5.14. Spain Market size and forecast, by service
TABLE 50. SPAIN FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 470.53 214.79 263.50 331.08 387.37 447.15 512.60 581.37 655.41 17.3%
Frozen Non-donor 181.08 80.91 97.14 119.40 136.63 154.19 172.74 191.40 210.72 14.7%
Egg & Embryo

100.93 46.93 58.62 74.95 89.21 104.71 122.01 140.60 160.99 19.3%
Banking
Fresh Donor 53.54 23.56 27.82 33.62 37.77 41.82 45.90 49.77 53.55 12.4%
Frozen Donor 49.27 22.79 28.33 36.06 42.73 49.94 57.95 66.52 75.87 18.7%
Total 855.35 388.99 475.41 595.11 693.71 797.81 911.21 1,029.67 1,156.54 16.8%
Global Fertility
Services Market
2020-2027
123
7.3.5.15. Spain Market size and forecast, by end user
TABLE 51. SPAIN FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 226.84 104.12 128.42 162.22 190.81 221.40 255.12 290.82 329.50 17.9%
Clinical Research
92.63 41.14 49.06 59.90 68.05 76.23 84.74 93.13 101.66 13.8%
Institutes
Total 855.35 388.99 475.41 595.11 693.71 797.81 911.21 1,029.67 1,156.54 16.8%
Global Fertility
Services Market
2020-2027
124
7.3.5.16. Russia market size and forecast, by procedure
The Russia fertility services market was valued at $565.28 million in 2019, and is projected to reach $982.51
contributor to the Russia fertility services market with $346.74 million in 2019 and is estimated to reach $647.47
TABLE 52. RUSSIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 346.74 165.66 212.03 277.18 336.58 402.32 476.63 557.66 647.47 21.5%
IUI 54.95 24.97 30.34 37.59 43.17 48.70 54.32 59.67 64.85 14.6%
IVF without ICSI 153.25 72.33 91.45 118.11 141.70 167.37 195.94 226.56 259.97 20.1%
Surrogacy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 10.34 4.63 5.54 6.74 7.59 8.38 9.11 9.72 10.22 12.0%
Total 565.28 267.59 339.36 439.62 529.04 626.77 736.00 853.60 982.51 20.4%
Global Fertility
Services Market
2020-2027
125
7.3.5.17. Russia Market size and forecast, by service
TABLE 53. RUSSIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 280.38 133.30 169.78 220.89 266.95 317.61 374.55 436.23 504.22 20.9%
Frozen Non-donor 119.67 55.66 69.34 88.20 104.19 121.13 139.53 158.67 179.01 18.2%
Egg & Embryo

66.70 32.28 41.84 55.37 68.03 82.26 98.55 116.56 136.76 22.9%
Banking
Fresh Donor 35.39 16.21 19.86 24.83 28.81 32.85 37.08 41.26 45.49 15.9%
Frozen Donor 63.14 30.14 38.53 50.33 61.05 72.91 86.30 100.87 117.02 21.4%
Total 565.28 267.59 339.36 439.62 529.04 626.77 736.00 853.60 982.51 20.4%
Global Fertility
Services Market
2020-2027
126
7.3.5.18. Russia market size and forecast, by end user
TABLE 54. RUSSIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 151.27 72.19 92.28 120.49 146.15 174.50 206.50 241.34 279.92 21.4%
Clinical Research
59.86 27.74 34.41 43.59 51.26 59.32 68.01 76.95 86.36 17.6%
Institutes
Total 565.28 267.59 339.36 439.62 529.04 626.77 736.00 853.60 982.51 20.4%
Global Fertility
Services Market
2020-2027
127
7.3.5.19. Rest of Europe market size and forecast, by procedure
The rest of Europe fertility services market accounted for $513.99 million in 2019, and is expected to reach
$422.01 million by 2027, growing at a CAGR of 9.7% during the forecast period. The IVF with ICSI segment was
the highest contributor to the rest of Europe fertility services market with $217.83 million in 2019 and is
estimated to reach $181.00 million by 2027, growing at a CAGR of 9.9%.
TABLE 55. REST OF EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 217.83 93.63 108.05 127.57 140.08 151.54 162.56 172.22 181.00 9.9%
IUI 140.83 60.26 69.23 81.37 88.96 95.80 102.31 107.90 112.89 9.4%
IVF without ICSI 104.49 44.47 50.81 59.39 64.56 69.14 73.41 76.97 80.05 8.8%
Surrogacy 25.60 11.46 13.74 16.84 19.17 21.47 23.81 26.04 28.23 13.8%
Others 25.24 10.77 12.35 14.48 15.79 16.96 18.07 19.01 19.83 9.1%
Total 513.99 220.59 254.18 299.65 328.55 354.91 380.15 402.14 422.01 9.7%
Global Fertility
Services Market
2020-2027
128
7.3.5.20. Rest of Europe market size and forecast, by service
$422.01 million by 2027, growing at a CAGR of 9.7% during the forecast period. The fresh non-donor segment
was the highest contributor to the rest of Europe fertility services market with $280.48 million in 2019 and is
estimated to reach $224.59 million by 2027, growing at a CAGR of 9.4% during the forecast period. Frozen
donor segment is anticipated to grow at the fastest CAGR of 13.8% during the forecast period.
TABLE 56. REST OF EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 280.48 120.00 137.85 162.00 177.07 190.68 203.60 214.70 224.59 9.4%
Frozen Non-donor 110.56 47.27 54.26 63.72 69.60 74.90 79.92 84.21 88.03 9.3%
Egg & Embryo

59.16 25.42 29.33 34.61 38.00 41.09 44.07 46.67 49.04 9.8%
Banking
Fresh Donor 33.20 14.21 16.32 19.18 20.96 22.57 24.10 25.42 26.59 9.4%
Frozen Donor 30.58 13.69 16.43 20.13 22.92 25.66 28.46 31.14 33.76 13.8%
Total 513.99 220.59 254.18 299.65 328.55 354.91 380.15 402.14 422.01 9.7%
Global Fertility Source: Primary Research, Government Publications, Company Releases, and AMR Analysis
Services Market
2020-2027
129
7.3.5.21. Rest of Europe market size and forecast, by end user
$422.01 million by 2027, growing at a CAGR of 9.7% from 2020 to 2027. The fertility clinics segment was the
highest contributor to the rest of Europe fertility services market with $265.01 million in 2019 and is estimated
to reach $205.81 million by 2027, growing at a CAGR of 8.9% during the forecast period. The surgical centers
segment is anticipated to grow at the fastest CAGR of 11.8% during the forecast period.
TABLE 57. REST OF EUROPE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 136.21 58.43 67.31 79.32 86.93 93.88 100.51 106.29 111.49 9.7%
Clinical Research
56.54 24.57 28.65 34.19 37.93 41.46 44.92 48.07 51.02 11.0%
Institutes
Total 513.99 220.59 254.18 299.65 328.55 354.91 380.15 402.14 422.01 9.7%
Global Fertility
Services Market
2020-2027
130
7.4. Asia-Pacific
Asia-Pacific includes India, China, Japan, Australia, and other Asia-Pacific countries. The fertility services market
in Japan, China, and India generated significant revenue in the global market in 2019. In addition, the fertility
services in countries such as India are cheaper as compare to the developed countries such as the U.S., Canada,
and others; thereby, fueling the market growth of fertility services in this region. The growth of the fertility
services market is supplemented by surge in adoption of fertility procedures and rise in fertility tourism. On the
other hand, poor technological outreach and cultural barriers of fertility services, especially IVF procedures in
the less developed countries of Asia-Pacific are anticipated to restrict the market growth.

The Asia-Pacific IVF services market is anticipated to exhibit significant growth during the forecast period, owing
to rise in infertility rate, increase in trend of late pregnancies, surge in IVF success rate, and rise in disposable
income in the region. IVF is one of the widely used treatments that assists people with infertility problems,
including couples, single mothers, and the LGBT community. Moreover, rise in fertility tourism provides steady
prospects for the growth of the IVF services market in Asia-Pacific. In addition, increase in number of fertility
clinics and growth opportunities in emerging markets are expected to boost the fertility services market growth
in the future.
Global Fertility
Services Market
2020-2027
131
The Asia-Pacific fertility services market was valued at $9,859.93 million in 2019, and is projected to reach
$14,497.67 million by 2027, growing at a CAGR of 18.1% from 2020 to 2027. China was the highest contributor
to the Asia-Pacific fertility services market with $3,643.24 million in 2019, and is estimated to reach $7,074.86
million by 2027. India and china are expected to be the fastest growing region, registering a CAGR of 22.2%
during the forecast period.
TABLE 58. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)

CAGR%
COUNTRY 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Japan 2,440.33 1,087.65 1,301.72 1,594.33 1,816.69 2,040.31 2,273.20 2,502.85 2,735.71 14.1%
India 656.67 313.92 402.73 528.53 645.13 776.07 926.21 1,092.64 1,280.14 22.2%
China 3,643.24 1,740.58 2,231.75 2,927.27 3,571.33 4,294.20 5,122.80 6,040.89 7,074.86 22.2%
Australia 557.09 246.66 293.14 356.33 402.74 448.36 494.82 539.22 582.81 13.1%
South Korea 1,284.75 567.21 671.97 814.05 916.68 1,016.40 1,116.76 1,211.05 1,301.89 12.6%
Rest of Asia-
1,277.85 573.04 690.28 851.26 977.07 1,105.83 1,242.21 1,379.73 1,522.26 15.0%
Pacific
Services Market
2020-2027
132
7.4.3. Asia-Pacific market size and forecast, by procedure
The Asia-Pacific fertility services market was valued at $9,859.93 million in 2019, and is projected to reach
$14,497.67 million by 2027, growing at a CAGR of 18.1% from 2020 to 2027. The IVF with ICSI segment market
accounted for $5,862.00 million in 2019, and is expected to reach $9,187.02 million by 2027, growing at a CAGR
TABLE 59. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 5,862.00 2,714.00 3,377.35 4,305.44 5,111.82 5,988.89 6,969.20 8,025.09 9,187.02 19.0%
IUI 958.56 427.00 510.42 623.93 708.96 793.25 879.59 962.70 1,044.63 13.6%
IVF without ICSI 2,788.06 1,277.71 1,573.79 1,985.72 2,333.40 2,705.56 3,115.83 3,550.62 4,022.33 17.8%
Surrogacy 137.39 59.76 69.74 83.23 92.34 100.87 109.21 116.72 123.70 11.0%
Others 113.91 50.59 60.28 73.43 83.11 92.59 102.18 111.24 119.98 13.1%
Total 9,859.93 4,529.06 5,591.60 7,071.76 8,329.64 9,681.16 11,176.00 12,766.37 14,497.67 18.1%
Global Fertility
Services Market
2020-2027
133
7.4.4. Asia-Pacific market size and forecast, by service
The Fresh non-donor segment market accounted for $5,345.29 million in 2019, and is expected to reach
$8,102.12 million by 2027, growing at a CAGR of 18.5% during the forecast period. The egg and embryo banking
TABLE 60. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 5,345.29 2,464.34 3,053.80 3,876.68 4,583.55 5,347.64 6,197.19 7,106.64 8,102.12 18.5%
Frozen Non-
2,142.11 967.68 1,174.49 1,459.67 1,688.83 1,927.21 2,183.40 2,446.54 2,724.00 15.9%
donor
Egg & Embryo

1,212.27 568.01 715.06 921.80 1,106.31 1,309.70 1,539.52 1,790.11 2,068.66 20.3%
Banking
Fresh Donor 606.03 269.69 322.20 393.84 447.77 501.62 557.31 611.68 666.23 13.8%
Frozen Donor 554.23 259.33 326.04 419.77 503.18 594.98 698.58 811.40 936.65 20.1%
Total 9,859.93 4,529.06 5,591.60 7,071.76 8,329.64 9,681.16 11,176.00 12,766.37 14,497.67 18.1%
Global Fertility
Services Market
2020-2027
134
7.4.5. Asia-Pacific market size and forecast, by end user
The fertility clinics segment market accounted for $5,155.25 million in 2019, and is expected to reach $7,170.99
million by 2027, growing at a CAGR of 17.3% during the forecast period. The surgical centers segment is
anticipated to grow at the fastest CAGR of 21.3% during the forecast period.
TABLE 61. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 2,580.53 1,195.28 1,488.04 1,897.66 2,253.82 2,641.28 3,074.40 3,540.94 4,054.33 19.1%
Surgical Centers 1,094.25 517.53 657.46 855.06 1,035.08 1,235.69 1,464.44 1,716.44 1,999.05 21.3%
Clinical
Research 1,029.91 463.86 561.23 695.22 801.62 911.51 1,028.83 1,148.31 1,273.30 15.5%
Institutes
Total 9,859.93 4,529.06 5,591.60 7,071.76 8,329.64 9,681.16 11,176.00 12,766.37 14,497.67 18.1%
Global Fertility
Services Market
2020-2027
135
7.4.5.1. Japan market size and forecast, by procedure
The Japan fertility services market accounted for $2,440.33 million in 2019 and is expected to reach $2,735.71
million by 2027, growing at a CAGR of 14.1% during the forecast period. The IVF with ICSI segment market
TABLE 62. JAPAN FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 1,176.97 526.74 633.00 778.45 890.63 1,004.31 1,123.47 1,241.94 1,362.93 14.5%
IUI 501.00 223.42 267.54 327.85 373.78 420.02 468.22 515.81 564.10 14.1%
IVF without ICSI 607.64 269.90 321.92 392.92 446.18 499.36 554.43 608.32 662.59 13.7%
Surrogacy 100.79 43.68 50.80 60.41 66.76 72.66 78.37 83.44 88.09 10.5%
Others 53.93 23.91 28.48 34.70 39.33 43.94 48.70 53.34 58.00 13.5%
Total 2,440.33 1,087.65 1,301.72 1,594.33 1,816.69 2,040.31 2,273.20 2,502.85 2,735.71 14.1%
Global Fertility
Services Market
2020-2027
136
7.4.5.2. Japan market size and forecast, by service
TABLE 63. JAPAN FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 1,342.43 600.58 721.48 886.96 1,014.44 1,143.54 1,278.79 1,413.17 1,550.33 14.5%
Frozen Non-donor 516.62 226.25 265.97 319.88 357.80 394.31 430.94 465.25 498.45 11.9%
Egg & Embryo

287.96 131.23 160.50 200.81 233.63 267.79 304.38 341.76 380.81 16.4%
Banking
Fresh Donor 152.76 65.87 76.18 90.06 98.92 106.94 114.51 120.98 126.66 9.8%
Frozen Donor 140.56 63.74 77.58 96.62 111.91 127.72 144.58 161.68 179.46 15.9%
Total 2,440.33 1,087.65 1,301.72 1,594.33 1,816.69 2,040.31 2,273.20 2,502.85 2,735.71 14.1%
Global Fertility
Services Market
2020-2027
137
7.4.5.3. Japan market size and forecast, by end user
TABLE 64. JAPAN FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fertility Clinics 1,258.24 557.00 662.09 805.35 911.34 1,016.40 1,124.49 1,229.37 1,334.21 13.3%
Hospitals 653.03 293.41 353.97 436.99 501.86 568.05 637.80 707.65 779.40 15.0%
Clinical Research
258.43 112.74 131.99 158.08 176.04 193.11 210.04 225.63 240.47 11.4%
Institutes
Total 2,440.33 1,087.65 1,301.72 1,594.33 1,816.69 2,040.31 2,273.20 2,502.85 2,735.71 14.1%
Global Fertility
Services Market
2020-2027
138
7.4.5.4. India market size and forecast, by procedure
The India fertility services market accounted for $656.67 million in 2019, and is expected to reach $1,280.14
accounted for $390.00 million in 2019, and is expected to reach $831.07 million by 2027, growing at a CAGR of
23.6% during the forecast period. The Indian government banned commercial surrogacy practice in August
2019.
TABLE 65. INDIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 390.00 188.61 244.75 324.85 400.98 487.73 588.49 701.79 831.07 23.6%
IUI 66.26 29.87 36.00 44.21 50.26 55.99 61.50 66.27 70.28 13.0%
IVF without ICSI 184.39 88.23 113.30 148.83 181.83 218.94 261.54 308.82 362.15 22.4%
Surrogacy 4.40 2.02 2.48 3.11 3.61 4.13 4.68 5.22 5.76 16.2%
Others 11.62 5.20 6.20 7.53 8.45 9.27 10.00 10.54 10.88 11.1%
Total 656.67 313.92 402.73 528.53 645.13 776.07 926.21 1,092.64 1,280.14 22.2%
Global Fertility
Services Market
2020-2027
139
7.4.5.5. India Market size and forecast, by service
The Fresh non-donor segment market accounted for $361.23 million in 2019, and is expected to reach $725.46
million by 2027, growing at a CAGR of 22.7% during the forecast period. The egg and embryo banking segment
is anticipated to grow at the fastest CAGR of 24.8% during the forecast period.
TABLE 66. INDIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 361.23 173.34 223.22 294.03 360.24 434.97 521.04 616.93 725.46 22.7%
Frozen Non-donor 139.02 65.30 82.29 106.04 127.06 149.98 175.59 203.11 233.24 19.9%
Egg & Embryo

77.49 37.87 49.66 66.57 82.96 101.86 124.02 149.20 178.20 24.8%
Banking
Fresh Donor 41.11 19.01 23.57 29.86 35.13 40.68 46.66 52.82 59.27 17.6%
Frozen Donor 37.82 18.40 24.00 32.03 39.74 48.58 58.91 70.58 83.98 24.2%
Total 656.67 313.92 402.73 528.53 645.13 776.07 926.21 1,092.64 1,280.14 22.2%
Global Fertility
Services Market
2020-2027
140
7.4.5.6. India market size and forecast, by end user
The fertility clinics segment market accounted for $338.58 million in 2019, and is expected to reach $624.33
TABLE 67. INDIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 175.73 84.68 109.51 144.86 178.22 216.07 259.87 308.93 364.71 23.2%
Clinical Research
69.54 32.54 40.84 52.40 62.51 73.45 85.58 98.50 112.52 19.4%
Institutes
Total 656.67 313.92 402.73 528.53 645.13 776.07 926.21 1,092.64 1,280.14 22.2%
Global Fertility
Services Market
2020-2027
141
7.4.5.7. China market size and forecast, by procedure
The China fertility services market accounted for $3,643.24 million in 2019, and is expected to reach $7,074.86
TABLE 68. CHINA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 2,382.68 1,144.34 1,474.96 1,944.73 2,384.93 2,882.48 3,456.35 4,096.63 4,822.23 22.8%
IUI 136.62 62.33 76.16 94.95 109.82 124.80 140.24 155.18 169.80 15.4%
IVF without ICSI 1,100.62 523.22 667.52 871.15 1,057.47 1,265.07 1,501.49 1,761.52 2,052.42 21.6%
Surrogacy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 23.32 10.68 13.11 16.43 19.11 21.85 24.72 27.56 30.42 16.1%
Total 3,643.24 1,740.58 2,231.75 2,927.27 3,571.33 4,294.20 5,122.80 6,040.89 7,074.86 22.2%
Global Fertility
Services Market
2020-2027
142
7.4.5.8. China Market size and forecast, by service
TABLE 69. CHINA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 2,004.15 961.10 1,236.95 1,628.51 1,994.23 2,406.79 2,881.83 3,410.84 4,009.32 22.6%
Frozen Non-donor 771.27 362.06 456.00 587.32 703.37 829.91 971.16 1,122.93 1,289.04 19.9%
Egg & Embryo

429.90 210.00 275.17 368.69 459.27 563.61 685.94 824.88 984.82 24.7%
Banking
Fresh Donor 228.07 105.41 130.61 165.35 194.46 225.07 258.06 292.00 327.57 17.6%
Frozen Donor 209.85 102.00 133.01 177.39 219.99 268.82 325.81 390.24 464.11 24.2%
Total 3,643.24 1,740.58 2,231.75 2,927.27 3,571.33 4,294.20 5,122.80 6,040.89 7,074.86 22.2%
Global Fertility
Services Market
2020-2027
143
7.4.5.9. China Market size and forecast, by end user
TABLE 70. CHINA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fertility Clinics 1,878.46 891.37 1,135.12 1,478.67 1,791.56 2,139.21 2,534.12 2,967.21 3,450.41 21.3%
Hospitals 974.93 469.54 606.87 802.33 986.58 1,195.56 1,437.33 1,707.98 2,015.63 23.1%
Clinical Research
385.82 180.41 226.30 290.24 346.06 406.45 473.35 544.59 621.88 19.3%
Institutes
Total 3,643.24 1,740.58 2,231.75 2,927.27 3,571.33 4,294.20 5,122.80 6,040.89 7,074.86 22.2%
Global Fertility
Services Market
2020-2027
144
7.4.5.10. Australia market size and forecast, by procedure
The Australia fertility services market accounted for $557.09 million in 2019, and is expected to reach $582.81
TABLE 71. AUSTRALIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 237.37 105.74 126.42 154.60 175.77 196.85 218.52 239.53 260.40 13.7%
IUI 168.41 73.98 87.22 105.18 117.92 130.21 142.53 154.04 165.11 12.2%
IVF without ICSI 135.76 60.16 71.54 87.02 98.43 109.66 121.11 132.07 142.85 13.2%
Surrogacy 2.79 1.25 1.50 1.85 2.11 2.38 2.66 2.93 3.21 14.4%
Others 12.76 5.54 6.45 7.68 8.50 9.26 10.00 10.65 11.25 10.7%
Total 557.09 246.66 293.14 356.33 402.74 448.36 494.82 539.22 582.81 13.1%
Global Fertility
Services Market
2020-2027
145
7.4.5.11. Australia Market size and forecast, by service
The fresh non-donor segment market accounted for $227.79 million in 2019, and is expected to reach $216.57
TABLE 72. AUSTRALIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 227.79 99.71 117.13 140.72 157.17 172.88 188.49 202.89 216.57 11.7%
Frozen Non-donor 172.70 76.89 91.88 112.31 127.63 142.86 158.51 173.67 188.71 13.7%
Egg & Embryo

114.54 51.34 61.76 75.99 86.91 97.90 109.31 120.49 131.71 14.4%
Banking
Fresh Donor 23.68 10.34 12.11 14.50 16.15 17.71 19.25 20.65 21.97 11.4%
Frozen Donor 18.38 8.38 10.25 12.81 14.88 17.01 19.26 21.52 23.84 16.1%
Total 557.09 246.66 293.14 356.33 402.74 448.36 494.82 539.22 582.81 13.1%
Global Fertility
Services Market
2020-2027
146
7.4.5.12. Australia Market size and forecast, by end user
TABLE 73. AUSTRALIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 91.08 40.05 47.26 57.04 64.02 70.76 77.53 83.87 89.99 12.3%
Clinical Research
44.73 19.99 23.96 29.39 33.51 37.63 41.89 46.04 50.18 14.1%
Institutes
Total 557.09 246.66 293.14 356.33 402.74 448.36 494.82 539.22 582.81 13.1%
Global Fertility
Services Market
2020-2027
147
7.4.5.13. South Korea market size and forecast, by procedure
The South Korea fertility services market accounted for $1,284.75 million in 2019, and is expected to reach
$1,301.89 million by 2027, growing at a CAGR of 12.6% during the forecast period. The IVF with ICSI segment
market accounted for $875.68 million in 2019, and is expected to reach $913.02 million by 2027, growing at a
TABLE 74. SOUTH KOREA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 875.68 388.01 461.32 560.87 633.84 705.29 777.69 846.33 913.02 13.0%
IUI 26.85 11.60 13.44 15.91 17.51 18.96 20.33 21.50 22.52 9.9%
IVF without ICSI 373.09 163.59 192.47 231.55 258.92 285.06 310.99 334.84 357.37 11.8%
Surrogacy 5.78 2.57 3.07 3.75 4.26 4.76 5.28 5.77 6.25 13.5%
Others 3.34 1.44 1.66 1.96 2.15 2.33 2.48 2.62 2.73 9.6%
Total 1,284.75 567.21 671.97 814.05 916.68 1,016.40 1,116.76 1,211.05 1,301.89 12.6%
Global Fertility
Services Market
2020-2027
148
7.4.5.14. South Korea market size and forecast, by service
TABLE 75. SOUTH KOREA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 706.74 313.20 372.44 452.88 511.87 569.67 628.23 683.79 737.78 13.0%
Frozen Non-donor 271.98 117.99 137.30 163.33 180.54 196.43 211.71 225.12 237.20 10.5%
Egg & Embryo

151.60 68.43 82.85 102.53 117.88 133.40 149.53 165.37 181.22 14.9%
Banking
Fresh Donor 80.43 34.35 39.33 45.98 49.91 53.27 56.26 58.54 60.28 8.4%
Frozen Donor 74.00 33.24 40.05 49.33 56.47 63.63 71.03 78.23 85.40 14.4%
Total 1,284.75 567.21 671.97 814.05 916.68 1,016.40 1,116.76 1,211.05 1,301.89 12.6%
Global Fertility
Services Market
2020-2027
149
7.4.5.15. South Korea market size and forecast, by end user
TABLE 76. SOUTH KOREA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 343.80 153.01 182.73 223.12 253.23 282.98 313.34 342.41 370.91 13.5%
Clinical Research
136.05 58.79 68.14 80.71 88.83 96.20 103.19 109.18 114.44 10.0%
Institutes
Total 1,284.75 567.21 671.97 814.05 916.68 1,016.40 1,116.76 1,211.05 1,301.89 12.6%
Global Fertility
Services Market
2020-2027
150
7.4.5.16. Rest of Asia-Pacific market size and forecast, by procedure
The rest of Asia-Pacific fertility services market accounted for $1,277.85 million in 2019, and is expected to reach
$1,522.26 million by 2027, growing at a CAGR of 15.0% during the forecast period. The IVF with ICSI segment
market accounted for $799.29 million in 2019, and is expected to reach $997.38 million by 2027, growing at a
TABLE 77. ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 799.29 360.56 436.90 541.95 625.66 712.22 804.67 898.87 997.38 15.6%
IUI 59.42 25.80 30.06 35.82 39.67 43.27 46.77 49.91 52.82 10.8%
IVF without ICSI 386.55 172.61 207.05 254.25 290.58 327.46 366.27 405.05 444.96 14.5%
Surrogacy 23.64 10.24 11.89 14.12 15.58 16.93 18.23 19.37 20.40 10.4%
Others 8.94 3.83 4.38 5.13 5.57 5.94 6.27 6.52 6.70 8.3%
Total 1,277.85 573.04 690.28 851.26 977.07 1,105.83 1,242.21 1,379.73 1,522.26 15.0%
Global Fertility
Services Market
2020-2027
151
7.4.5.17. Rest of Asia-Pacific Market size and forecast, by service
TABLE 78. REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 702.94 316.42 382.59 473.58 545.59 619.79 698.81 779.03 862.66 15.4%
Frozen Non-donor 270.52 119.20 141.04 170.80 192.43 213.72 235.49 256.47 277.35 12.8%
Egg & Embryo

150.79 69.14 85.11 107.22 125.65 145.14 166.33 188.40 211.90 17.4%
Banking
Fresh Donor 79.99 34.70 40.40 48.09 53.20 57.96 62.58 66.69 70.48 10.7%
Frozen Donor 73.60 33.58 41.14 51.59 60.19 69.23 79.00 89.13 99.86 16.8%
Total 1,277.85 573.04 690.28 851.26 977.07 1,105.83 1,242.21 1,379.73 1,522.26 15.0%
Global Fertility
Services Market
2020-2027
152
7.4.5.18. Rest of Asia-Pacific market size and forecast, by end user
TABLE 79. REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 341.95 154.58 187.71 233.32 269.91 307.88 348.53 390.10 433.69 15.9%
Clinical Research
135.32 59.40 69.99 84.40 94.68 104.67 114.78 124.38 133.81 12.3%
Institutes
Total 1,277.85 573.04 690.28 851.26 977.07 1,105.83 1,242.21 1,379.73 1,522.26 15.0%
Global Fertility
Services Market
2020-2027
153
7.5. LAMEA
The key factors that contribute toward the growth of the LAMEA market include rise in medical tourism across
Latin America and Middle East countries. Latin American countries, such as Brazil, Peru, Guyana, Ecuador, and
Argentina, have regular access for fertility treatments. The surrogacy and infertility treatments in this region
have limited development due to the presence of stringent regulations. For instance, countries such as Brazil
and others banned commercial surrogacy.

The regulations with respect to fertility services are changing drastically, for instance, in 2000, Costa Rica became
the only country in the western hemisphere to ban IVF when its constitutional court stated that IVF creates
excess embryos and violates right to life. Moreover, in 2012, the Inter-American Court of Human Rights (IACHR)
ruled that the IVF ban violates the rights to personal integrity, liberty, privacy, and to form a family. However, in
2016, the IACHR ruled that IVF must be allowed in Costa Rica. The legal regulations for IVF are not the same in
every region. In South Africa, altruistic surrogacy arrangements are only enforceable subject to confirmation by
the High Court and commercial surrogacy arrangements are not enforceable under South African law and
surrogates may only claim pregnancy-related expenses.
Global Fertility The Latin American Network of Assisted Reproduction (REDLARA) reported that in 2010 Argentina had 8,336
Services Market ART procedures compared an increase to 14,980 in 2014. The same occurred in Brazil in 2010 which had 17,673
Opportunity Analysis ART procedures compared to 27,269 in 2014. Chile had 1,652 in 2010 and 3,791 in 2014. Also, REDLARA reported
and Industry Forecast, that a total of 128,245 children were born in Latin America. This attributes to the growth of the fertility services
2020-2027
market during the forecast period.
154
The LAMEA fertility services market was valued at $1,467.98 million in 2019 and is projected to reach $1,231.49
million by 2027, growing at a CAGR of 10.0% from 2020 to 2027. Middle East was the highest contributor to the
LAMEA fertility services market with $975.18 million in 2019 and is estimated to reach $845.30 million by 2027.
Middle East is also expected to be the fastest growing region, registering a CAGR of 10.4% during the forecast
period.
TABLE 80. LAMEA FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)

CAGR%
COUNTRY 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Latin America 294.77 126.91 146.63 173.26 190.31 205.81 220.53 233.18 244.33 9.8%
Middle East 975.18 422.22 490.60 582.96 643.90 700.26 754.54 802.26 845.30 10.4%
Africa 198.03 83.83 95.20 110.52 119.23 126.59 133.12 138.08 141.87 7.8%
Total 1,467.98 632.95 732.43 866.74 953.44 1,032.66 1,108.20 1,173.52 1,231.49 10.0%
Global Fertility
Services Market
2020-2027
155
7.5.3. LAMEA market size and forecast, by procedure
million by 2027, growing at a CAGR of 10.0% from 2020 to 2027. The IVF with ICSI segment market accounted
for $879.10 million in 2019, and is expected to reach $715.54 million by 2027, growing at a CAGR of 9.6% during
TABLE 81. LAMEA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 879.10 377.66 435.40 513.33 562.56 607.00 648.91 684.51 715.54 9.6%
IUI 96.88 43.84 53.13 65.72 75.43 85.10 94.98 104.46 113.70 14.6%
IVF without ICSI 437.72 188.43 217.70 257.24 282.56 305.61 327.52 346.39 363.05 9.8%
Surrogacy 6.53 2.99 3.67 4.59 5.32 6.07 6.84 7.59 8.34 15.8%
Others 47.75 20.03 22.52 25.87 27.58 28.89 29.95 30.57 30.86 6.4%
Total 1,467.98 632.95 732.43 866.74 953.44 1,032.66 1,108.20 1,173.52 1,231.49 10.0%
Global Fertility
Services Market
2020-2027
156
7.5.4. LAMEA market size and forecast, by service
million by 2027, growing at a CAGR of 10.0% from 2020 to 2027. The fresh non-donor segment market
TABLE 82. LAMEA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 807.54 349.50 405.95 482.19 532.40 578.78 623.42 662.60 697.89 10.4%
Frozen Non-donor 310.77 131.66 149.65 173.90 187.78 199.57 210.09 218.14 224.38 7.9%
Egg & Embryo

173.22 76.37 90.31 109.17 122.61 135.54 148.39 160.24 171.42 12.2%
Banking
Fresh Donor 93.67 39.82 45.42 52.99 57.45 61.33 64.86 67.97 70.54 8.5%
Frozen Donor 82.78 35.61 41.09 48.50 53.19 57.44 61.44 64.57 67.26 9.5%
Total 1,467.98 632.95 732.43 866.74 953.44 1,032.66 1,108.20 1,173.52 1,231.49 10.0%
Global Fertility
Services Market
2020-2027
157
7.5.5. LAMEA market size and forecast, by end user
million by 2027, growing at a CAGR of 10.0% from 2020 to 2027. The fertility clinics segment market accounted
TABLE 83. LAMEA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 392.83 170.75 199.17 237.56 263.39 287.51 310.93 331.80 350.85 10.8%
Clinical Research
155.46 65.61 74.27 85.94 92.39 97.74 102.40 105.79 108.25 7.4%
Institutes
Total 1,467.98 632.95 732.43 866.74 953.44 1,032.66 1,108.20 1,173.52 1,231.49 10.0%
Global Fertility
Services Market
2020-2027
158
7.5.5.1. Latin America market size and forecast, by procedure
The Latin America fertility services market was valued at $294.77 million in 2019 and is projected to reach
$244.33 million by 2027, growing at a CAGR of 9.8% from 2020 to 2027. The IVF with ICSI segment market
TABLE 84. LATIN AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 173.50 74.56 85.99 101.42 111.20 120.03 128.38 135.49 141.71 9.6%
IUI 35.23 15.63 18.59 22.60 25.51 28.34 31.17 33.80 36.31 12.8%
IVF without ICSI 76.88 32.71 37.34 43.59 47.30 50.52 53.46 55.81 57.73 8.5%
Surrogacy 3.04 1.39 1.70 2.12 2.45 2.78 3.12 3.44 3.76 15.3%
Others 6.13 2.62 3.01 3.53 3.85 4.14 4.41 4.63 4.81 9.1%
Total 294.77 126.91 146.63 173.26 190.31 205.81 220.53 233.18 244.33 9.8%
Global Fertility
Services Market
2020-2027
159
7.5.5.2. Latin America market size and forecast, by service
$244.33 million by 2027, growing at a CAGR of 9.8% from 2020 to 2027. The fresh non-donor segment market
TABLE 85. LATIN AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 162.15 70.07 81.27 96.39 106.27 115.35 124.06 131.66 138.46 10.2%
Frozen Non-donor 62.40 26.40 29.96 34.76 37.48 39.78 41.81 43.34 44.52 7.8%
Egg & Embryo

34.78 15.31 18.08 21.82 24.47 27.01 29.53 31.84 34.01 12.1%
Banking
Fresh Donor 18.57 7.82 8.83 10.20 10.94 11.55 12.07 12.45 12.71 7.2%
Frozen Donor 16.86 7.30 8.49 10.09 11.14 12.12 13.06 13.89 14.64 10.4%
Total 294.77 126.91 146.63 173.26 190.31 205.81 220.53 233.18 244.33 9.8%
Global Fertility
Services Market
2020-2027
160
7.5.5.3. Latin America market size and forecast, by end user
$244.33 million by 2027, growing at a CAGR of 9.8% from 2020 to 2027. The fertility clinics segment market
TABLE 86. LATIN AMERICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 78.88 34.23 39.87 47.49 52.57 57.30 61.88 65.93 69.61 10.7%
Clinical Research
31.22 13.15 14.87 17.18 18.44 19.48 20.38 21.02 21.48 7.3%
Institutes
Total 294.77 126.91 146.63 173.26 190.31 205.81 220.53 233.18 244.33 9.8%
Global Fertility
Services Market
2020-2027
161
7.5.5.4. Middle East market size and forecast
The Middle East fertility services market was valued at $975.18 million in 2019 and is projected to reach $845.30
TABLE 87. MIDDLE EAST FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 577.89 249.09 288.13 340.83 374.75 405.70 435.15 460.54 483.00 9.9%
IUI 55.10 25.27 31.01 38.80 45.01 51.29 57.80 64.14 70.41 15.8%
IVF without ICSI 300.84 130.52 151.98 180.96 200.29 218.26 235.66 251.08 265.08 10.7%
Surrogacy 3.22 1.49 1.85 2.34 2.74 3.14 3.57 3.98 4.40 16.7%
Others 38.13 15.84 17.64 20.04 21.12 21.87 22.37 22.52 22.40 5.1%
Total 975.18 422.22 490.60 582.96 643.90 700.26 754.54 802.26 845.30 10.4%
Global Fertility
Services Market
2020-2027
162
7.5.5.5. Middle East market size and forecast, by service
million by 2027, growing at a CAGR of 10.4% from 2020 to 2027. The fresh non-donor segment market
TABLE 88. MIDDLE EAST FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 536.45 233.14 271.91 324.31 359.56 392.48 424.47 452.98 479.03 10.8%
Frozen Non-donor 206.45 87.83 100.24 116.96 126.82 135.33 143.04 149.13 154.01 8.4%
Egg & Embryo

115.07 50.94 60.49 73.42 82.81 91.91 101.03 109.55 117.67 12.7%
Banking
Fresh Donor 62.70 26.92 31.02 36.54 40.02 43.14 46.08 48.57 50.72 9.5%
Frozen Donor 54.51 23.39 26.93 31.71 34.71 37.39 39.92 42.04 43.87 9.4%
Total 975.18 422.22 490.60 582.96 643.90 700.26 754.54 802.26 845.30 10.4%
Global Fertility
Services Market
2020-2027
163
7.5.5.6. Middle East market size and forecast, by end user
million by 2027, growing at a CAGR of 10.4% from 2020 to 2027. The fertility clinics segment market accounted
TABLE 89. MIDDLE EAST FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 260.96 113.90 133.41 159.78 177.88 194.96 211.71 226.83 240.82 11.3%
Clinical Research
103.27 43.76 49.75 57.80 62.39 66.28 69.72 72.32 74.30 7.9%
Institutes
Total 975.18 422.22 490.60 582.96 643.90 700.26 754.54 802.26 845.30 10.4%
Global Fertility
Services Market
2020-2027
164
7.5.5.7. Africa market size and forecast
The Africa fertility services market was valued at $198.03 million in 2019 and is projected to reach $141.87
TABLE 90. AFRICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)

CAGR%
PROCEDURE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
IVF with ICSI 127.71 54.01 61.28 71.08 76.61 81.27 85.38 88.48 90.82 7.7%
IUI 6.55 2.94 3.53 4.33 4.91 5.46 6.01 6.52 6.98 13.1%
IVF without ICSI 60.00 25.20 28.38 32.68 34.97 36.82 38.40 39.49 40.23 6.9%
Surrogacy 0.28 0.11 0.12 0.13 0.14 0.15 0.16 0.17 0.18 7.4%
Others 3.49 1.56 1.88 2.30 2.61 2.89 3.17 3.42 3.65 12.8%
Total 198.03 83.83 95.20 110.52 119.23 126.59 133.12 138.08 141.87 7.8%
Global Fertility
Services Market
2020-2027
165
7.5.5.8. Africa market size and forecast, by service
million by 2027, growing at a CAGR of 7.8% from 2020 to 2027. The fresh non-donor segment market accounted
TABLE 91. AFRICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)

CAGR%
SERVICE 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Fresh Non-donor 108.94 46.29 52.76 61.49 66.58 70.95 74.89 77.96 80.40 8.2%
Frozen Non-donor 41.92 17.44 19.45 22.17 23.48 24.47 25.24 25.67 25.85 5.8%
Egg & Embryo

23.37 10.11 11.74 13.92 15.33 16.62 17.83 18.85 19.75 10.0%
Banking
Fresh Donor 12.40 5.08 5.57 6.24 6.49 6.63 6.71 6.96 7.12 5.0%
Frozen Donor 11.41 4.91 5.67 6.70 7.34 7.92 8.47 8.64 8.75 8.6%
Total 198.03 83.83 95.20 110.52 119.23 126.59 133.12 138.08 141.87 7.8%
Global Fertility
Services Market
2020-2027
166
7.5.5.9. Africa market size and forecast, by end user
million by 2027, growing at a CAGR of 7.8% from 2020 to 2027. The fresh non-donor segment market accounted
TABLE 92. AFRICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
CAGR%
END USER 2019 2020 2021 2022 2023 2024 2025 2026 2027
(2020–2027)
Hospitals 52.99 22.61 25.89 30.29 32.94 35.24 37.35 39.04 40.42 8.7%
Clinical Research
20.97 8.69 9.65 10.96 11.55 11.98 12.30 12.45 12.47 5.3%
Institutes
Total 198.03 83.83 95.20 110.52 119.23 126.59 133.12 138.08 141.87 7.8%
Global Fertility
Services Market
2020-2027
167
CHAPTER 8: COMPANY PROFILES
8.1. APOLLO HOSPITALS ENTERPRISE LTD.
No 19 Bishop Gardens
Raja Annamalaipuram
Chennai, 600 028
India
Tel.: + 91-44-2829-0200
Website: www.apollohospitals.com
8.1.1. Company overview

Apollo Hospitals Enterprise Ltd. (Apollo Hospitals) is the first corporate hospital based in India and a leading
integrated healthcare services provider. It is well known across the healthcare ecosystem, including hospitals,
pharmacies, and primary care & diagnostic clinics. The group is involved in telemedicine units across 10
countries, health insurance services, global projects consultancy, medical colleges, Medvarsity for E-Learning,
colleges of nursing & hospital management, and research foundation. It runs 24-hour pharmacy network across
India.
Global Fertility
Services Market
2020-2027
168
8.1.2. Company snapshot
TABLE 93. APOLLO HOSPITALS: COMPANY SNAPSHOT
Information Description
Year of Incorporation 1983
Dr. Prathap C. Reddy (Founder and Chairman)

Key Executive(s)
Dr. Preetha Reddy (Vice Chairperson)
Primary Business Healthcare services and pharmacy
Geographical Presence India
Key Strategic Moves Business expansion
2020: 1,518.3
Overall Financial Status ($Million) 2019: 1,365.9
2018: 1,206.9
Workforce 62,939 (as of March 31, 2020)
Source: Corporate Publications and AMR Analysis
8.1.3. Operating business segments

Apollo Hospitals operates its business through the following three reportable segments:
Global Fertility TABLE 94. APOLLO HOSPITALS: OPERATING SEGMENTS
Services Market Segment Description
Opportunity Analysis Healthcare Services Consists of hospitals, hospital-based pharmacies, and projects & consultancy services
2020-2027 Retail Pharmacy Operates 3,766 retail pharmacies
169
Segment Description
Provides project consultancy services, health insurance services, education and training programs, and
Others
research services. It also operates birthing centers, day surgery centers, and dental clinics
8.1.4. Product portfolio

Apollo Hospitals offers the following infertility treatments:
TABLE 95. APOLLO HOSPITALS: PRODUCT PORTFOLIO
Product Category Brand/Product
 Fallopian tube problems

 Endometriosis
Surgical Treatment  Polycystic ovary
 Fibroids
 Male Infertility
 IUI (Intra Uterine Insemination)

 IVF (In vitro Fertilization)
 ICSI (Intra Cytoplasmic Sperm Injection)
Assisted Conception  TESA (Testicular Sperm Aspiration)
Global Fertility  Embryo Freezing Excess (Surplus)
Services Market  Assisted Hatching

 Semen/Sperm Freezing
Opportunity Analysis Source: Corporate Publications and AMR Analysis
2020-2027
170
8.1.5. Business performance
Apollo Hospitals registered a growth rate of 11.2% from 2019 to 2020 due to increased demand for its services,
R&D, and expanded business.
FIGURE 12. APOLLO HOSPITALS: NET SALES, 2018 2020 ($MILLION)
Net Sales ($Million)
1,518.3
1,365.9
1,206.9
2018 2019 2020

Global Fertility
Services Market
2020-2027
171
FIGURE 13. APOLLO HOSPITALS: REVENUE SHARE BY SEGMENT, 2020 (%)
0.0%
6.2% Healthcare services
Retail Pharmacy
51.0%
42.8%
Clinics
Others
8.1.6. Key strategic moves and developments

Apollo Hospitals adopted business expansion as its key developmental strategy to sustain the intense
competition and improve its product portfolio.
Date Strategy Description
Apollo Fertility, a part of the Apollo Health & Lifestyle and Apollo Hospitals group, announced
Global Fertility January 2021 Business expansion its expansion into Northern India with the establishment of its first, state-of-the-art
standalone fertility centre in Noida
Services Market Source: Corporate Publications and AMR Analysis
2020-2027
172
8.2. CARE FERTILITY GROUP LTD.
John Webster House 6
Lawrence Drive
Nottingham, NG8 6PZ
UK
Tel.: 44-115-852-8100
Website: www.carefertility.com

Care Fertility Group Ltd. (Care Fertility) is a global fertility group that offers effective fertility treatments using
various technologies such as CAREmaps and chromosome screening. It provides a wide range of treatments
and additional procedures including IUI, IVF, and ICSI. In addition, it provides various genetic techniques to
diagnose genetic illnesses and conditions, or examine embryos on a genetic level.

TABLE 96. CARE FERTILITY: COMPANY SNAPSHOT
Global Fertility Information Description
Services Market Year of Incorporation 1997
Opportunity Analysis Key Executive(s) Simon Fishel (President)

Primary Business Fertility services
2020-2027
Geographical Presence Europe
173
Workforce 63

Care Fertility operates its business through a single segment—fertility services.

Care Fertility offers the following fertility services:
TABLE 97. CARE FERTILITY: PRODUCT PORTFOLIO
 IVF – In vitro fertilization

 Intra cytoplasmic sperm injection (ICSI)
Fertility Treatments
 Intrauterine Insemination (IUI)
 IVF diagnostic tests
 CAREmaps
Global Fertility Embryology Treatments  EmbryoGen and BlastGen
Services Market  EmbryoGlue
Opportunity Analysis  Egg freezing and storage

and Industry Forecast,  EGGsafe
2020-2027 Fertility Preservation
 Embryo freezing and storage
 Freezing sperm
174
 Pre-implantation genetic diagnosis (PGD)

Genetics  Pre-implantation genetic screening (PGS)
 NIPT - Reassurance testing in early pregnancy
 Fertility Test
Fertility Assessments  Female fertility assessments
 Male fertility assessments

Care Fertility adopted business expansion as its key developmental strategy to sustain the intense competition
and improve its product portfolio.
July 12, 2017 Business expansion CARE Fertility Group opened a new IVF center at 27 Highfield Road, Edgbaston
Global Fertility
Services Market
2020-2027
175
8.3. CAROLINAS FERTILITY INSTITUTE
311 W. Wendover Ave.
Greensboro 27408
U.S.
Tel.: +1-336-448-9100
Website: www.carolinasfertilityinstitute.com

Carolinas Fertility Institute provides fertility treatment, which includes services such as ovulation induction,
intrauterine insemination, in vitro fertilization, donor egg, fertility preservation, robotic surgery, and minimally
invasive surgery. Moreover, it offers fertility testing, which includes female fertility evaluation, and male fertility
evaluation.

TABLE 98. CAROLINAS FERTILITY INSTITUTE: COMPANY SNAPSHOT

Global Fertility Dr. Tamer Yalcinkaya (Founder)
Services Market Key Executive(s)
Dr. Tolga Mesen (Director)
Opportunity Analysis Primary Business Fertility services

and Industry Forecast, Geographical Presence North America
2020-2027
Workforce 21
176
Carolinas Fertility Institute operates its business through a single segment—fertility services.

Carolinas Fertility Institute offers the following fertility services:
TABLE 99. CAROLINAS FERTILITY INSTITUTE: PRODUCT PORTFOLIO
 Ovulation Induction
 Intrauterine Insemination (IUI)
 In Vitro Fertilization
Fertility Services  Donor Egg
 Fertility Preservation
 Robotic & Minimally Invasive Surgery
 Ovest – Egg Preservation
Global Fertility
Services Market
2020-2027
177
8.4. CITY FERTILITY
L 8 259 Wickham Tce
Brisbane City, Queensland, 4000
Australia
Tel.: + 1300354354
Website: www.cityfertility.com.au

City fertility offers IVF & fertility service groups with 57 consulting rooms, 40 doctors, and 7 clinics across the
country. It is involved in science-based treatments and research projects. City fertility offers fertility services and
treatments such as IVF services, fertility preservation, and donor programs. In addition, it provides support
services such as coping with infertility, counsellors, dietitians, and complementary therapies.

TABLE 100. CITY FERTILITY: COMPANY SNAPSHOT

Global Fertility Key Executive(s) Teck Liang Beng (Director)
Services Market Primary Business Fertility services
Opportunity Analysis Geographical Presence Australia

and Industry Forecast, Key Strategic Moves Product launch
2020-2027
Workforce 45
178
City fertility operates its business through a single segment—fertility services.

City fertility offers the following fertility services:
TABLE 101. CITY FERTILITY: PRODUCT PORTFOLIO
 Fertility health check

 Male fertility testing
Fertility Tests & Early Treatments
 Ovulation induction
 Artificial insemination
 IVF treatment  EmbryoGen & BlastGen culture media

 ICSI treatment  Embryo transfer media
IVF Services
 Testicular biopsy & sperm extraction  Laser-assisted hatching
 Blastocyst stage extended culture  Genetic testing
 Sperm freezing
Fertility Preservation
 Egg freezing
Global Fertility
 Using donor sperm
Services Market
 Using donor eggs
Opportunity Analysis Donor Program  Using donor embryos
and Industry Forecast,  Donating sperm
2020-2027  Donating eggs
179
 Donating embryos
 Single women
 Lesbian couples
 Surrogacy
 Legalities
 Coping with infertility

 Counsellors
Support Services
 Dietitians
 Complementary therapies

City fertility adopted product launch as its key developmental strategy to sustain the intense competition and
improve its product portfolio.
City fertility launched women’s egg freezing service-Chill in Australia. This Chill service
June 27, 2019 Product launch
preserves women fertility and egg quality through freezing eggs
Global Fertility Source: Corporate Publications and AMR Analysis
Services Market
2020-2027
180
8.5. FERTILITY ASSOCIATES LIMITED
Level 3, 7 Ellerslie Racecourse Drive
Ellerslie Auckland,
New Zealand
Tel.: + 09-520-9520
Website: www.fertilityassociates.co.nz

Fertility Associates Limited (Fertility Associates) provides fertility diagnosis, support, and treatment. It offers
services related to fertility & reproductive health including endocrinology services, gynecology services,
obstetrics services, and genetic services. In addition, it provides nutrition services, counselling services, and
vasectomy reversal services. Moreover, it provides fertility technologies such as pre-implantation genetic
screening (PGS), time lapse morphometry imaging (TiMI), IMSI, and endometrial receptivity assay (ERA).

TABLE 102. FERTILITY ASSOCIATES: COMPANY SNAPSHOT
Global Fertility Year of Incorporation 1987
Services Market Key Executive(s) Simon Kelly (Director)
Opportunity Analysis Primary Business Fertility services

and Industry Forecast, Geographical Presence New Zealand and Malaysia
2020-2027
Workforce 69
181
Fertility associates operates its business through the following two segments:
TABLE 103. FERTILITY ASSOCIATES: OPERATING SEGMENTS
Segment Description
Provides endocrinology services, gynecology services, obstetrics services, genetic services, nutrition
Fertility Services
services, counselling services, and vasectomy reversal services
Offers pre-implantation genetic screening (PGS), time lapse morphometry imaging (TiMI), IMSI, and
Fertility Technologies
endometrial receptivity assay (ERA)

Fertility associates offers the following fertility services:
TABLE 104. FERTILITY ASSOCIATES: PRODUCT PORTFOLIO
 Ovulation induction (OI)

 Intra uterine insemination (IUI)
Fertility Services  In vitro fertilization (IVF)
Global Fertility  Donor options and surrogacy
Services Market  Fertility preservation

2020-2027
182
8.6. GENEA LIMITED
Level 2/321 Kent Street
Sydney NSW 2000
Australia
Tel.: +61-2-9229-6420
Website: www.genea.com.au

Genea Limited provides assisted reproductive technology (ART) services. It operates through four segments,
which include Genea Fertility, Genea Biomedx, Genea Consult, and Genea Biocells. It offers ART services for
couples through a network of fertility treatment clinics, as well as ART-related consulting services.
In addition, it designs, manufactures, and sells IVF equipment, consumables, and media. Moreover, it is involved
in the discovery stage drug development activities related to neuromuscular diseases. Formerly, it was known
as Sydney IVF Limited and it renamed to Genea Limited in November 2011.
Global Fertility
Services Market
2020-2027
183
TABLE 105. GENEA LIMITED: COMPANY SNAPSHOT
Key Executive(s) Rowan Ross AM (Chairman and CEO)
Primary Business Fertility treatments
Geographical Presence Australia and New Zealand
Key Strategic Moves Partnership
Workforce 350

Genea Limited operates its business through four reportable segments:
TABLE 106. GENEA LIMITED: OPERATING SEGMENTS
Segment Description
Develops world-class technologies used in over 60 countries and 600 clinics worldwide, while having
Genea Fertility
Global Fertility some of Australia's leading IVF success rates
Services Market Genea Consult

Offers priority access to world leading technologies and industry leading minds and provides ongoing
support
Transforms expertise into practical, accessible, and precise technology that aims to significantly
Opportunity Analysis Genea Biomedx
improve lab outcomes and ultimately patient outcomes
2020-2027 Supplies and develops disease-specific pluripotent and differentiated human stem cells for use in drug
Genea Biocells
development and research
184
Genea Limited offers the following fertility services:
TABLE 107. GENEA LIMITED: PRODUCT PORTFOLIO
 Male infertility
 Female trouble conceiving
 Male tests
Fertility Tests  Female tests
 Fertility treatments
 Genetic testing
 Egg freezing
 Ovulation induction
 IVF
Fertility Treatments  IUI
 ICSI
 Freezing
Global Fertility
Services Market
2020-2027
185
Genea Limited adopted partnership as its key developmental strategy to sustain the intense competition and
Genea biomedx (subsidiary of Genea limited) and hamilton thorne partner to grow genea
biomedx operations. Under the terms of the collaboration agreement, Hamilton Thorne will
November 12, 2020 Partnership
exclusively commercialize and market Genea Biomedx’s flagship fertility technologies and
products in the United States and Canada.
Genea limited and Zip Co Limited, an Australian financial technology company, entered into
October 30, 2018 Partnership strategic partnership to make in vitro fertilization more accessible by providing interest free
instalments on IVF cycle costs
Genea and Merck, a leading science and technology company, opened its first center of
January 20, 2017 Business expansion excellence (CoE) for fertility. The center aims to optimize procedures to improve treatment
outcomes for couples that want to conceive
Global Fertility
Services Market
2020-2027
186
8.7. MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)
Riddargatan 12A
PO Box 55720
Stockholm, 114 83
Sweden
Tel.: +46-8-622-3600
Website: www.medicover.com

Medicover Group (Medicover) is global leader in healthcare and diagnostic services, offering a wide range of
high-quality healthcare services and a significant hub-and-spoke diagnostic laboratory network. It has
operations in Poland, Germany, Romania, Ukraine, and certain other markets in Western Europe, Central and
Eastern Europe, and other emerging markets. Medicover Fertility is a subsidiary of Medicover, which offers
fertility services and treatments along with its subsidiaries. First Egg Bank is the largest European egg donor
bank, which is part of Medicover Fertility. Medicover has 91 clinical laboratories and 454 blood drawing points
(BDPS). It performed 115 million diagnostic tests in 2017.
Global Fertility
Services Market
2020-2027
187
TABLE 108. MEDICOVER: COMPANY SNAPSHOT
Fredrik Ragmark (CEO)

Key Executive(s)
Joe Ryan (CFO)
Primary Business Healthcare services and diagnostics services
Geographical Presence Poland, Germany, Romania, Ukraine, and others
2020: 1,139.7
Overall Financial Status ($Million) 2019: 945.3
2018: 793.1
Workforce 32,387 (as of December 31, 2020)

Medicover operates its business through two reportable segments:
TABLE 109. MEDICOVER: OPERATING SEGMENTS
Global Fertility Segment Description
Services Market Healthcare Services

Offers outpatient and inpatient healthcare services, which include fertility treatment, dental, elderly
care, eye care, and skin and wellness services as well as fitness and pharmacy solutions
Opportunity Analysis Provides various tests, which include allergy and autoimmune diagnostics, bacteriology, parasitology,
and Industry Forecast, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumor markers,
Diagnostic Services
2020-2027 clinical chemistry, cytology, hematology, histopathology, human genetics, hygiene, immunology and
immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology
188
8.7.4. roduct portfolio
Medicover offers various fertility services through portfolio of its subsidiary named as Medicover Fertility and
First Egg Bank.
TABLE 110. MEDICOVER: PRODUCT PORTFOLIO
 Female Fertility
 IUI
 IVF
 IVF with Donor Egg
 Surrogacy
 Male Fertility
Medicover Fertility Treatments  ICSI
 IVF with Donor Sperm
 Surgical Sperm Retrieval
 Fertility Preservation
 Egg Freezing
 Sperm Freezing
Global Fertility  Embryo Freezing
Services Market  Egg Donation

First Egg Bank’s Fertility Services  Egg Freezing
Opportunity Analysis  Embryo Donation
2020-2027
189
Medicover registered a growth rate of 20.6% from 2019 to 2020 due to increased sales in healthcare services
segment, service extensions, distribution reach, and higher volume of members.
FIGURE 14. MEDICOVER: NET SALES, 2018 2020 ($MILLION)
1,139.7
945.3
793.1
2018 2019 2020

Global Fertility
Services Market
2020-2027
190
FIGURE 15. MEDICOVER: REVENUE SHARE BY SEGMENT, 2020 (%)
Diagnostic Services
46,7%
53,3%
Healthcare Services
FIGURE 16. MEDICOVER: REVENUE SHARE BY REGION, 2020 (%)
Poland
7.0%
8.0%
Germany
8.0% 40.0%
Romania
Global Fertility 13.0% India
Services Market Ukraine

24.0%
Opportunity Analysis Other
2020-2027 Source: Corporate Publications and AMR Analysis
191
8.8. MONASH IVF GROUP LIMITED
Pelaco Building L 1,
21-31, Goodwood Street
Richmond, VIC 3121
Australia
Tel.: + 61 3 9420 8235
Website: www.monashivfgroup.com.

The Monash IVF Group Limited (MVF) develops assisted reproductive technologies (ART) and tertiary level
prenatal diagnostics. Monash IVF Group acquired fertility east in Bondi Sydney and Sydney’s leading supplier
of tertiary level diagnostic ultrasound. It offers a wide range of specialist diagnostic obstetric & gynecological
ultrasound and fertility treatments. In addition, its treatments and services are delivered in a professional and
caring environment with help of specialists, scientists, sonographers, nurses, and counsellors.

TABLE 111. MVF: COMPANY SNAPSHOT
Global Fertility Information Description
Services Market Year of Incorporation 1973
Opportunity Analysis Michael D. Knaap (CEO)

Key Executive(s)
and Industry Forecast, Brett Comer (COO)
2020-2027 Primary Business Fertility services
192
Geographical Presence Australia and Malaysia
Key Strategic Moves Acquisition
2020: 145.4
2018: 150.6

MVF operates its business through a single segment—fertility services.

MVF offers the following fertility services:
TABLE 112. MVF: PRODUCT PORTFOLIO
 IVF Services: In Vitro Fertilization (IVF), IVF Process, and Intra Cytoplasmic Sperm Injection (ICSI)
Fertility Treatments  Early Intervention Options: Egg Timer Test, Timed Intercourse, Ovulation Induction, IUI – Assisted
Insemination, Natural and Complementary Therapies, and Ultrasound for Women
Global Fertility
 Fertility Preservation for Medical Reasons
Services Market Fertility Preservation
 Egg Freezing – Social Reasons
Opportunity Analysis  Donor Sperm  Surrogacy

and Industry Forecast,  Donor Egg  Same Sex Couples
2020-2027 Donor & Surrogacy
 The World Egg Bank (TWEB)  Single Women
 Donor Embryo  Gender Diverse
193
 Preimplantation Genetic Diagnosis (PGD)

Genetic Testing  Preimplantation Genetic Screening (PGS)
 Non-Invasive Prenatal Testing (NIPT)

MVF registered a decreased of 4.3% from 2019 to 2020 due to decline in the international market and the
strategic repositioning of a low intervention clinic.
FIGURE 17. MVF: NET SALES, 2018 2020 ($MILLION)

152.0
150.6
Global Fertility
145.4
Services Market
Opportunity Analysis 2018 2019 2020
and Industry Forecast, Source: Corporate Publications and AMR Analysis
2020-2027
194
FIGURE 18. MVF: REVENUE SHARE BY REGION, 2020 (%)
6.8%
Monash IVF Group Australia
Monash IVF Group International

93.2%

MVF adopted acquisition as its key developmental strategy to sustain the intense competition and improve its
product portfolio.
Fertility Solutions, a privately owned and operated assisted reproductive service (ARS) clinic,
July 11, 2019 Acquisition acquired by Monash IVF Group. This acquisition was for creating a more balanced business
Global Fertility portfolio across Australia
Services Market Source: Corporate Publications and AMR Analysis
2020-2027
195
8.9. PROGYNY INC.
99 Hudson Street
7th Floor
New York, NY 10013
U.S.
Tel: +1-212-888-3124
Website: www.progyny.com

Progyny Inc. (Progyny) is a healthcare company that integrates service, science, technology, and data to provide
in vitro fertilization and fertility solutions to consumers and employers, in addition to providing health plans.
Progyny aims to improve the clinical outcomes of fertility treatments by using latest and best technologies. The
Progyny Suite of SMART Fertility Services includes a comprehensive national network of fertility clinics; clinic
quality and cost transparency; and personal concierge services delivered by Patient Care Advocates. Benefits
include egg freezing, IVF treatment, non-IVF fertility treatments, and medications.

Global Fertility TABLE 113. PROGYNY: COMPANY SNAPSHOT
Services Market Information Description
Opportunity Analysis Year of Incorporation 2008

and Industry Forecast, David Schlanger (CEO)
2020-2027 Key Executive(s)
Pete Anevski (Chief Financial & Operating Officer)
196
Primary Business Fertility services
Geographical Presence North America
2020: 344.9
2018: 105.4

Progyny operates its business through a fertility benefit services and pharmacy benefit services.

Progyny offers the following fertility treatments:
TABLE 114. PROGYNY: PRODUCT PORTFOLIO
 Intracytoplasmic Sperm Injection (ICSI)
Global Fertility Fertility Treatments

 Pre-implantation Genetic Screening (PGS)
Services Market  Assisted Hatching (AH)

 Vitrification (VIT)
Opportunity Analysis Source: Corporate Publications and AMR Analysis
2020-2027
197
Progyny registered an increase of 50.1% from 2019 to 2020 due to surge in fertility benefit services.
FIGURE 19. PROGYNY: NET SALES, 2018 2020 ($MILLION)
344.9
229.7
105.4
2018 2019 2020

Global Fertility
Services Market
2020-2027
198
FIGURE 20. PROGYNY: REVENUE SHARE BY SEGMENT, 2020 (%)
26.5% Fertility benefit services
73.5% Pharmacy benefit services

Progyny adopted business expansion as its key developmental strategy to sustain the intense competition and
Progyny raised $10 million from all existing investors, including lead investors Kleiner
Global Fertility May 2, 2017 Business expansion

Perkins Caufield and Byers (KPCB), TPG Biotech, and SR One, to finance Series B extension
that supports the company's mission of providing comprehensive and inclusive fertility
Services Market benefits that help people to conceive a child

2020-2027
199
8.10. VIRTUS HEALTH
176 Pacific Highway
Level 3
Greenwich, NSW 2065
Australia
Tel.: + 61 2 9425 1722
Website: www.virtushealth.com.au

Virtus Health offers fertility healthcare & related specialized diagnostics and day hospital services. It provides in
vitro fertilization (IVF) services, which include intrauterine insemination, intracytoplasmic injection, GIFT,
ovulation induction, frozen embryo transfer, blastocyst culture, egg & semen freezing, and storage. In addition,
it offers andrology services, endocrinology services, and cytogenetic diagnostic services. Moreover, it provides
day hospital procedures including gynecology, urology, IVF, cosmetic surgery, endoscopy, dental, plastic, and
ophthalmic surgery.

Global Fertility TABLE 115. VIRTUS HEALTH: COMPANY SNAPSHOT
Services Market Information Description
Opportunity Analysis Year of Incorporation 2008

and Industry Forecast, Susan Channon (CEO)
2020-2027 Key Executive(s)
Glenn Powers (CFO)
200
Primary Business Assisted reproductive services
Geographical Presence Australia, Ireland, UK, Denmark, and Singapore
2020: 258.9
2018: 263.9

Virtus Health operates its business through four reportable segments:
TABLE 116. VIRTUS HEALTH: OPERATING SEGMENTS
Segment Description
Australian ARS Provides service delivery to support patients across Australia
Australian Diagnostic Provides general pathology services, specialist fertility, and genetic testing
Provides dental & hand surgeons, fertility specialists, cosmetic, gynecologists, urologists, and
Day Hospitals
ophthalmologists
International ARS Provides service delivery to support patients across Ireland, the UK, Denmark, and Singapore
Global Fertility Source: Corporate Publications and AMR Analysis
Services Market
2020-2027
201
Virtus Health offers the following fertility services:
TABLE 117. VIRTUS HEALTH: PRODUCT PORTFOLIO
 Ovulation cycle tracking  Vasectomy reversal

 Ovulation induction  Digital high mag sperm
 Artificial insemination  Artificial intelligence in IVF
Fertility Treatments
 IVF treatment  Assisted hatching
 ICSI treatment  PolScope
 Frozen embryo transfer  Fertility surgery
 Female analysis
 Next generation sequencing
 Egg count (AMH) test
Fertility Test  Karyomapping
 Semen analysis
 Genetics clinic
 Genetic testing PGT
 Using donor sperm

 Single women
 Donating sperm
 Same sex couples
Donors & Surrogacy  Egg donation
 Donor SibLinks
Global Fertility  Embryo donation
 Fellas, get a grip
 Surrogacy
Services Market
 Female fertility preservation
Opportunity Analysis Fertility Preservation  Egg freezing
and Industry Forecast,  Male fertility preservation
2020-2027
202
Virtus health registered a decrease of 7.5% from 2019 to 2020 due to decline in international healthcare services.
FIGURE 21. VIRTUS HEALTH: NET SALES, 2018 2020 ($MILLION)
280.1
263.9
258.9
2018 2019 2020

Global Fertility
Services Market
2020-2027
203
FIGURE 22. VIRTUS HEALTH: REVENUE SHARE BY SEGMENT, 2020 (%)
Australian ARS
19.0%
Day Hospitals
9.0%
8.0% 64.0% Specialised Diagnostics
International/other
FIGURE 23. VIRTUS HEALTH: REVENUE SHARE BY REGION, 2020 (%)
19.4%
Healthcare Services Australia
Global Fertility
Services Market Healthcare Services International
80.6%
2020-2027 Source: Corporate Publications and AMR Analysis
204
Virtus health adopted collaboration as its key developmental strategy to sustain the intense competition and
Virtus Health, a leading global assisted reproductive services provide, announced a multi-
February 16, 2021 Collaboration year strategic collaboration, with CooperSurgical, a leader in women’s health care solutions,
to drive innovation, digitalization and advancement in fertility treatment.
Global Fertility
Services Market
2020-2027
205
DISCLAIMER
In response to request/orders received, Allied Market Research (AMR) provides strategic business/market analysis
services to a select group of customers that are limited to publications containing valuable market information. The
publication is solely for our customers’ internal use. It is acknowledged by our customer, by placing the order that
no part of this strategic business/market analysis service is for general publication or disclosure to third party.
AMR doesn’t make any warranty for the accuracy of the data as these are primarily based on interviews and
therefore, liable for fluctuation. Also, AMR doesn’t take responsibility for incorrect information supplied by
manufacturers or users.
Any resale, lending, disclosure or reproduction of this publication can only be made with prior written permission
from AMR.
Transmission and/or reproduction of this document by any means or in any form (includes photocopying,
mechanical, electronic, recording or otherwise) are prohibited without permission of AMR.
I/we acknowledge that I/we have read the terms and conditions, disclaimer, privacy policy, and GDPR policy
listed on Allied Market Research website and by placing the order online through credit card or wire transfer or any
other means, I/we do hereby accept the same.
Global Fertility
Services Market
Opportunity Analysis FOR INFORMATION REGARDING PERMISSIONS, CONTACT:
2020-2027 Tel: U.S.:+1 (503 894-6022) | UK: +44-845-528-1300
Email: sales@alliedmarketresearch.com
206

Global Fertility Services Market, 2020-2027

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Global Fertility Services Market, 2020-2027

Uploaded by

Copyright:

Available Formats

2021

FERTILITY SERVICES MARKET

EMISPDF in-pwc001 from 13.234.188.75 on 2021-11-26 05:24:03 GMT. DownloadPDF.

1.4. Research methodology ...............................................................................................31

1.4.2. Primary research ................................................................................................................... 33

1.4.3. Analyst tools & models ...................................................................................................... 34

CHAPTER 2: EXECUTIVE SUMMARY............................................................................ 35

Global Fertility 2.2. CXO perspective ..........................................................................................................37

Services Market CHAPTER 3: MARKET OVERVIEW ................................................................................ 39

3.3. Porter’s five force analysis .........................................................................................45

3.4.2. Europe ...................................................................................................................................... 51

3.5. Market dynamics .........................................................................................................53

3.5.1.1. Continuous decline in fertility rates ......................................................................... 54

3.5.2. Restraints ................................................................................................................................. 56

3.5.2.1. High treatment costs of ARTs in developed countries ..................................... 56

3.5.3. Opportunity ............................................................................................................................ 57

3.6. COVID-19 impact on the fertility services market ..................................................58

4.2. IVF with ICSI .................................................................................................................63

4.2.2. Market size and forecast.................................................................................................... 64

4.3. IUI ..................................................................................................................................65

4.3.2. Market size and forecast.................................................................................................... 66

4.4. IVF without ICSI ...........................................................................................................67

4.4.2. Market size and forecast.................................................................................................... 67

4.5. Surrogacy .....................................................................................................................68

5.2. Fresh non-donor ..........................................................................................................74

5.3. Frozen non-donor .......................................................................................................75

5.4. Egg & embryo banking ..............................................................................................77

5.5. Fresh donor ..................................................................................................................79

5.6. Frozen donor ...............................................................................................................81

6.4. Surgical centers ...........................................................................................................87

6.5. Clinical research institutes .........................................................................................88

CHAPTER 7: FERTILITY SERVICES MARKET, BY REGION .......................................... 89

7.2. North America .............................................................................................................91

7.2.2. Market size and forecast, by country ............................................................................ 92

7.3. Europe ....................................................................................................................... 105

7.3.2. Europe Market size and forecast, by country .......................................................... 106

7.3.3. Europe Market size and forecast, by procedure ..................................................... 107

7.3.4. Europe market size and forecast, by service ............................................................ 108

7.4. Asia-Pacific................................................................................................................ 131

7.4.4. Asia-Pacific market size and forecast, by service ................................................... 134

7.4.5.1. Japan market size and forecast, by procedure .................................................. 136

7.5. LAMEA ....................................................................................................................... 154

7.5.2. Market size and forecast, by country .......................................................................... 155

7.5.3. LAMEA market size and forecast, by procedure ..................................................... 156

7.5.4. LAMEA market size and forecast, by service ............................................................ 157

8.1.2. Company snapshot ............................................................................................................ 169

8.1.3. Operating business segments ....................................................................................... 169

8.1.4. Product portfolio ................................................................................................................ 170

8.1.5. Business performance....................................................................................................... 171

8.1.6. Key strategic moves and developments .................................................................... 172

8.2. CARE FERTILITY GROUP LTD................................................................................... 173

8.2.2. Company snapshot ............................................................................................................ 173

8.2.3. Operating business segments ....................................................................................... 174

8.2.4. Product portfolio ................................................................................................................ 174

8.2.5. Key strategic moves and developments .................................................................... 175

8.4. CITY FERTILITY .......................................................................................................... 178

8.4.2. Company snapshot ............................................................................................................ 178

8.4.3. Operating business segments ....................................................................................... 179

8.4.4. Product portfolio ................................................................................................................ 179

8.4.5. Key strategic moves and developments .................................................................... 180

8.5. FERTILITY ASSOCIATES LIMITED ............................................................................ 181

8.5.2. Company snapshot ............................................................................................................ 181

8.5.3. Operating business segments ....................................................................................... 182

8.5.4. Product portfolio ................................................................................................................ 182